BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-781. [PMID: 20116997 DOI: 10.1016/j.ejca.2009.12.014] [Cited by in Crossref: 1529] [Cited by in F6Publishing: 1408] [Article Influence: 127.4] [Reference Citation Analysis]
Number Citing Articles
1 Crouzet S, Murat FJ, Pasticier G, Cassier P, Chapelon JY, Gelet A. High intensity focused ultrasound (HIFU) for prostate cancer: Current clinical status, outcomes and future perspectives. International Journal of Hyperthermia 2010;26:796-803. [DOI: 10.3109/02656736.2010.498803] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
2 Al-khedhairy AA, Wahab R. Silver Nanoparticles: An Instantaneous Solution for Anticancer Activity against Human Liver (HepG2) and Breast (MCF-7) Cancer Cells. Metals 2022;12:148. [DOI: 10.3390/met12010148] [Reference Citation Analysis]
3 Pileri P, Campagnoli S, Grandi A, Parri M, De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P, Cinti C, Jin B, Grandi G, Viale G, Terracciano L, Grifantini R. FAT1: a potential target for monoclonal antibody therapy in colon cancer. Br J Cancer 2016;115:40-51. [PMID: 27328312 DOI: 10.1038/bjc.2016.145] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
4 Park S, Kim IR, Baek KK, Lee SJ, Chang WJ, Maeng CH, Hong JY, Choi MK, Kim YS, Sun JM, Ahn JS, Park K, Jo J, Jung SH, Ahn MJ. Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer. Ann Oncol 2013;24:1630-9. [PMID: 23393122 DOI: 10.1093/annonc/mds649] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
5 Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid H, van der Kwast T, Wiegel T, Zattoni F. EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease. Actas Urológicas Españolas (English Edition) 2011;35:501-14. [DOI: 10.1016/j.acuroe.2011.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kuzmickiene I, Everatt R. Trends and age-period-cohort analysis of upper aerodigestive tract and stomach cancer mortality in Lithuania, 1987-2016. Public Health 2021;196:62-8. [PMID: 34153634 DOI: 10.1016/j.puhe.2021.05.001] [Reference Citation Analysis]
7 Harrington JA, Jones RJ. Management of metastatic castration-resistant prostate cancer after first-line docetaxel. Eur J Cancer 2011;47:2133-42. [PMID: 21658937 DOI: 10.1016/j.ejca.2011.04.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
8 Frei R, Staedler D, Raja A, Franke R, Sasse F, Gerber-lemaire S, Waser J. Total Synthesis and Biological Evaluation of Jerantinine E. Angew Chem 2013;125:13615-8. [DOI: 10.1002/ange.201305533] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ho T, Gerber L, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol 2012;62:910-6. [PMID: 22921964 DOI: 10.1016/j.eururo.2012.08.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
10 Kossatz S, Béhé M, Mansi R, Saur D, Czerney P, Kaiser WA, Hilger I. Multifactorial diagnostic NIR imaging of CCK2R expressing tumors. Biomaterials 2013;34:5172-80. [PMID: 23591397 DOI: 10.1016/j.biomaterials.2013.03.073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
11 Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, Guinó E, Sanjuan X, Biondo S, Soriano A, Jurman G, Capella G, Furlanello C, Moreno V. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review. PLoS One 2012;7:e48877. [PMID: 23145004 DOI: 10.1371/journal.pone.0048877] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
12 de Boer AG, Bruinvels DJ, Tytgat KM, Schoorlemmer A, Klinkenbijl JH, Frings-Dresen MH. Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional study. BMJ Open 2011;1:e000190. [PMID: 22138895 DOI: 10.1136/bmjopen-2011-000190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
13 Monteiro Lde S, Bastos KX, Barbosa-Filho JM, de Athayde-Filho PF, Diniz Mde F, Sobral MV. Medicinal Plants and Other Living Organisms with Antitumor Potential against Lung Cancer. Evid Based Complement Alternat Med 2014;2014:604152. [PMID: 25147575 DOI: 10.1155/2014/604152] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
14 Lorente C, Arias JL, Cabeza L, Ortiz R, Prados JC, Melguizo C, Delgado ÁV, Clares-naveros B. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines. Journal of Pharmacy and Pharmacology 2018;70:488-97. [DOI: 10.1111/jphp.12882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-1403. [PMID: 23485231 DOI: 10.1016/j.ejca.2012.12.027] [Cited by in Crossref: 3292] [Cited by in F6Publishing: 2972] [Article Influence: 365.8] [Reference Citation Analysis]
16 Campa D, Hüsing A, Chang-Claude J, Dostal L, Boeing H, Kröger J, Tjønneland A, Roswall N, Overvad K, Dahm CC, Rodríguez L, Sala N, Pérez MJ, Larrañaga N, Chirlaque MD, Ardanaz E, Khaw KT, Wareham N, Allen NE, Travis RC, Trichopoulou A, Naska A, Bamia C, Palli D, Sieri S, Tumino R, Sacerdote C, van Kranen HJ, Bas Bueno-de-Mesquita H, Stattin P, Johansson M, Chajes V, Rinaldi S, Romieu I, Siddiq A, Norat T, Riboli E, Kaaks R, Canzian F. Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). Eur J Cancer 2011;47:420-7. [PMID: 20965718 DOI: 10.1016/j.ejca.2010.09.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Michielin O, Hoeller C. Gaining momentum: New options and opportunities for the treatment of advanced melanoma. Cancer Treatment Reviews 2015;41:660-70. [DOI: 10.1016/j.ctrv.2015.05.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
18 Camacho L, Meca-Cortés O, Abad JL, García S, Rubio N, Díaz A, Celià-Terrassa T, Cingolani F, Bermudo R, Fernández PL, Blanco J, Delgado A, Casas J, Fabriàs G, Thomson TM. Acid ceramidase as a therapeutic target in metastatic prostate cancer. J Lipid Res 2013;54:1207-20. [PMID: 23423838 DOI: 10.1194/jlr.M032375] [Cited by in Crossref: 52] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
19 Pan Z, Fu Z, Luo C, Bao Y, Wang M, Cao W, Xu X. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer. J Cancer Res Clin Oncol 2021. [PMID: 34537906 DOI: 10.1007/s00432-021-03775-4] [Reference Citation Analysis]
20 Verleye L, Vergote I, van der Zee AG. Patterns of care in surgery for ovarian cancer in Europe. Eur J Surg Oncol 2010;36 Suppl 1:S108-14. [PMID: 20580524 DOI: 10.1016/j.ejso.2010.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
21 Izumi K, Mizokami A, Itai S, Shima T, Shigehara K, Miwa S, Maeda Y, Konaka H, Koh E, Namiki M. Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis. BJU Int 2012;109:394-400. [PMID: 21599822 DOI: 10.1111/j.1464-410X.2011.10192.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
22 Tonry C, Armstrong J, Pennington SR. Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression. Oncotarget 2017;8:14374-94. [PMID: 28086232 DOI: 10.18632/oncotarget.14605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
23 Troisi J, Sarno L, Landolfi A, Scala G, Martinelli P, Venturella R, Di Cello A, Zullo F, Guida M. Metabolomic Signature of Endometrial Cancer. J Proteome Res 2018;17:804-12. [DOI: 10.1021/acs.jproteome.7b00503] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
24 Lorenc Z, Opiłka MN, Kruszniewska-Rajs C, Rajs A, Waniczek D, Starzewska M, Lorenc J, Mazurek U. Expression Level of Genes Coding for Cell Adhesion Molecules of Cadherin Group in Colorectal Cancer Patients. Med Sci Monit 2015;21:2031-40. [PMID: 26167814 DOI: 10.12659/MSM.893610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Viana Freitas BR, Kibune Nagasako C, Pavan CR, Silva Lorena SL, Guerrazzi F, Saddy Rodrigues Coy C, Ayrizono Mde L, Mesquita MA. Immunochemical fecal occult blood test for detection of advanced colonic adenomas and colorectal cancer: comparison with colonoscopy results. Gastroenterol Res Pract 2013;2013:384561. [PMID: 24319453 DOI: 10.1155/2013/384561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
26 Morales-barrera R, Suárez C, Valverde C, Nuñez I, Maldonado X, Morote J, Carles J. Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy? Clin Transl Oncol 2014;16:102-6. [DOI: 10.1007/s12094-013-1045-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
27 Grange F, Barbe C, Mas L, Granel‐brocard F, Lipsker D, Aubin F, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Reuter G, Bernard P, Woronoff A, Arnold F. The role of general practitioners in diagnosis of cutaneous melanoma: a population‐based study in France. British Journal of Dermatology 2012;167:1351-9. [DOI: 10.1111/j.1365-2133.2012.11178.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kulis T, Krhen I, Kastelan Z, Znaor A. Trends in prostate cancer incidence and mortality in Croatia, 1988-2008. Croat Med J 2012;53:109-14. [PMID: 22522988 DOI: 10.3325/cmj.2012.53.109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Duport N. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey. Revue d'Épidémiologie et de Santé Publique 2012;60:421-30. [DOI: 10.1016/j.respe.2012.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
30 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Keck B, Wach S, Kunath F, Bertz S, Taubert H, Lehmann J, Stöckle M, Wullich B, Hartmann A. Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder. Ann Surg Oncol 2013;20:2440-5. [DOI: 10.1245/s10434-012-2709-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
32 Hyun YS, Han DS, Bae JH, Park HS, Eun CS. Graduated injection needles and snares for polypectomy are useful for measuring colorectal polyp size. Dig Liver Dis 2011;43:391-4. [PMID: 21334993 DOI: 10.1016/j.dld.2010.12.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
33 Chih YP, Wu WT, Lin CL, Jou HJ, Huang YH, Chen LC, Chou LW. Vertebral Compression Fracture Related to Pancreatic Cancer With Osteoblastic Metastasis: A Case Report and Literature Review. Medicine (Baltimore) 2016;95:e2670. [PMID: 26844499 DOI: 10.1097/MD.0000000000002670] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Verhappen MH, Poortmans PM, Raaijmakers E, Raemaekers JM. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma. Radiother Oncol 2013;109:133-9. [PMID: 24021344 DOI: 10.1016/j.radonc.2013.07.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
35 van Boerdonk RA, Daniels JM, Bloemena E, Krijgsman O, Steenbergen RD, Brakenhoff RH, Grünberg K, Ylstra B, Meijer CJ, Smit EF, Snijders PJ, Heideman DA. High-Risk Human Papillomavirus–Positive Lung Cancer: Molecular Evidence for a Pattern of Pulmonary Metastasis. Journal of Thoracic Oncology 2013;8:711-8. [DOI: 10.1097/jto.0b013e3182897c14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
36 Pardo F, Osorio J, Miranda C, Castro S, Miró M, Luna A, Garsot E, Momblán D, Galofré G, Rodríguez-Santiago J, Pera M; Spanish EURECCA Oesophago-Gastric Cancer Group. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma. Clin Transl Oncol 2020;22:1335-44. [PMID: 31865605 DOI: 10.1007/s12094-019-02261-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Ahrens W, Pohlabeln H, Foraita R, Nelis M, Lagiou P, Lagiou A, Bouchardy C, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane GJ, Lee YA, Talamini R, Barzan L, Canova C, Simonato L, Thomson P, Mckinney PA, Mcmahon AD, Znaor A, Healy CM, Mccartan BE, Metspalu A, Marron M, Hashibe M, Conway DI, Brennan P. Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: The ARCAGE study. Oral Oncology 2014;50:616-25. [DOI: 10.1016/j.oraloncology.2014.03.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
38 Serrano C, Morales R, Suárez C, Núñez I, Valverde C, Rodón J, Humbert J, Padrós O, Carles J. Emerging therapies for urothelial cancer. Cancer Treat Rev 2012;38:311-7. [PMID: 22113129 DOI: 10.1016/j.ctrv.2011.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
39 Maritschnegg E, Wang Y, Pecha N, Horvat R, Van Nieuwenhuysen E, Vergote I, Heitz F, Sehouli J, Kinde I, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Speiser P, Zeillinger R. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study. J Clin Oncol 2015;33:4293-300. [PMID: 26552420 DOI: 10.1200/JCO.2015.61.3083] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
40 O'Regan R, Hawk NN. mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy. Expert Opin Ther Targets 2011;15:859-72. [PMID: 21476875 DOI: 10.1517/14728222.2011.575362] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
41 Morgia G, Castelli T, Privitera S, Al-nakib C, Favilla V, Marchese F, Cimino S, Russo GI. Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I 125 implant brachytherapy for prostate cancer. A longitudinal study of a single-institution. The Aging Male 2015;19:15-9. [DOI: 10.3109/13685538.2015.1083546] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Reumer A, Maes E, Mertens I, Cho WC, Landuyt B, Valkenborg D, Schoofs L, Baggerman G. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare? Expert Review of Proteomics 2014;11:449-63. [DOI: 10.1586/14789450.2014.905743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
43 Röcken C, Behrens HM, Böger C, Krüger S. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort. J Clin Pathol 2016;69:70-5. [PMID: 26251521 DOI: 10.1136/jclinpath-2015-202980] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
44 Fang WF, Chen YM, Lin CY, Huang KT, Kao HC, Fang YT, Huang CH, Chang YT, Wang YH, Wang CC, Lin MC. Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units. PLoS One 2017;12:e0179749. [PMID: 28692671 DOI: 10.1371/journal.pone.0179749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
45 van den Broek CB, Boelens PG, Breugom AJ, van de Velde CJ. Improving the outcome of colorectal cancer: the European Registration of Cancer Care (EURECCA) project. Colorectal Cancer 2013;2:371-6. [DOI: 10.2217/crc.13.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol. 2014;24:889-901. [PMID: 24322510 DOI: 10.1007/s00330-013-3083-8] [Cited by in Crossref: 137] [Cited by in F6Publishing: 111] [Article Influence: 15.2] [Reference Citation Analysis]
47 Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Sci Rep. 2017;7:43393. [PMID: 28262692 DOI: 10.1038/srep43393] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
48 Kasenda B, Bass A, Koeberle D, Pestalozzi B, Borner M, Herrmann R, Jost L, Lohri A, Hess V. Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer. 2014;14:728. [PMID: 25266049 DOI: 10.1186/1471-2407-14-728] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
49 Michl M, Thurmaier J, Schubert-Fritschle G, Wiedemann M, Laubender RP, Nüssler NC, Ruppert R, Kleeff J, Schepp W, Reuter C, Löhe F, Karthaus M, Neumann J, Kirchner T, Engel J, Heinemann V. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors. Clin Colorectal Cancer 2015;14:281-90. [PMID: 26123495 DOI: 10.1016/j.clcc.2015.05.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
50 Saylor PJ, Armstrong AJ, Fizazi K, Freedland S, Saad F, Smith MR, Tombal B, Pienta K. New and emerging therapies for bone metastases in genitourinary cancers. Eur Urol 2013;63:309-20. [PMID: 23201471 DOI: 10.1016/j.eururo.2012.10.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
51 Loum E, Giraud S, Bessette B, Battu S, Mathonnet M, Lautrette C. Oncogramme, a new individualized tumor response testing method: application to colon cancer. Cytotechnology 2010;62:381-8. [PMID: 20820914 DOI: 10.1007/s10616-010-9298-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W, Ji G. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer. 2011;129:887-895. [PMID: 20957628 DOI: 10.1002/ijc.25734] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
53 Alikhani R, Taravati A, Hashemi-Soteh MB. Association of MUC1 5640G>A and PSCA 5057C>T polymorphisms with the risk of gastric cancer in Northern Iran. BMC Med Genet 2020;21:148. [PMID: 32660489 DOI: 10.1186/s12881-020-01085-z] [Reference Citation Analysis]
54 Sadowska A, Krętowski R, Szynaka B, Cechowska-Pasko M, Car H. Metronidazole decreases viability of DLD-1 colorectal cancer cell line. Cancer Biother Radiopharm 2013;28:615-22. [PMID: 23777253 DOI: 10.1089/cbr.2013.1485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Chabrera C, Font A, Caro M, Areal J, Zabalegui A. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer. Cancer Nurs 2015;38:E55-60. [PMID: 24831045 DOI: 10.1097/NCC.0000000000000140] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 Clèries R, Esteban L, Borràs J, Marcos-Gragera R, Freitas A, Carulla M, Buxó M, Puigdefàbregas A, Izquierdo A, Gispert R, Galceran J, Ribes J. Time trends of cancer incidence and mortality in Catalonia during 1993-2007. Clin Transl Oncol 2014;16:18-28. [PMID: 23740137 DOI: 10.1007/s12094-013-1060-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
57 Kjaerheim K, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Effects of occupation on risks of avoidable cancers in the Nordic countries. Eur J Cancer 2010;46:2545-54. [PMID: 20843484 DOI: 10.1016/j.ejca.2010.07.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
58 Sara Mahdavi S, Moradi M, Wen X, Morris WJ, Salcudean SE. Evaluation of visualization of the prostate gland in vibro-elastography images. Medical Image Analysis 2011;15:589-600. [DOI: 10.1016/j.media.2011.03.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
59 Gao Y, Gao F, Ma JL, Sun WZ, Song LP. The potential clinical applications and prospects of microRNAs in lung cancer. Onco Targets Ther 2014;7:901-6. [PMID: 24940074 DOI: 10.2147/OTT.S62227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
60 Coletta M, Montalti R, Pistelli M, Vincenzi P, Mocchegiani F, Vivarelli M. Metastatic breast cancer mimicking a hilar cholangiocarcinoma: case report and review of the literature. World J Surg Oncol. 2014;12:384. [PMID: 25515643 DOI: 10.1186/1477-7819-12-384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
61 Shylasree TS, Kattepur AK, Gupta M, Ghosh J, Maheshwari A, Bajpai J, Hawaldar R, Gulia S, Deodhar K, Popat P, Gupta S, Kerkar RA. Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancer. Cancer Rep (Hoboken) 2020;3:e1217. [PMID: 32671995 DOI: 10.1002/cnr2.1217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Piciu A, Andrianou XD, Irimie A, Bălăcescu O, Zira C, BĂRBUş E, Peştean C, Aristeidou K, Theofanous T, Agathokleous M, Piciu D, Makris KC. Investigation of thyroid nodules in the female population in Cyprus and in Romania. Clujul Med 2015;88:494-9. [PMID: 26733748 DOI: 10.15386/cjmed-518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Qu XM, Biagi JJ, Hopman WM, Mahmud A. Shifting practice in definitive chemoradiation for localized esophageal cancer. Curr Oncol 2017;24:e379-87. [PMID: 29089808 DOI: 10.3747/co.24.3677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
64 Hofmarcher T, Lindgren P, Wilking N, Jönsson B. The cost of cancer in Europe 2018. European Journal of Cancer 2020;129:41-9. [DOI: 10.1016/j.ejca.2020.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
65 Lei F, Chen JY, Wang WC, Lin LM, Huang HC, Ho KY, Chen YK. Retrospective study of oral and maxillofacial lesions in older Taiwanese patients. Gerodontology 2015;32:281-7. [PMID: 26780481 DOI: 10.1111/ger.12118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
66 Konings IC, Harinck F, Kuenen MA, Sidharta GN, Kieffer JM, Aalfs CM, Poley JW, Smets EM, Wagner A, van Rens A, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ, Bleiker EM; Dutch research group on pancreatic cancer surveillance in high-risk individuals. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer 2017;16:143-51. [PMID: 27629874 DOI: 10.1007/s10689-016-9930-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
67 Ni S, Hu J, Duan Y, Shi S, Li R, Wu H, Qu Y, Li Y. Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer. Cancer Sci 2013;104:817-25. [PMID: 23521319 DOI: 10.1111/cas.12157] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
68 Barach YS, Lee JS, Zang X. T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Trends Mol Med 2011;17:47-55. [PMID: 20971039 DOI: 10.1016/j.molmed.2010.09.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
69 Pardini B, Naccarati A, Vodicka P, Kumar R. Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk. Mutagenesis 2012;27:161-7. [PMID: 22294763 DOI: 10.1093/mutage/ger057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
70 Morishita A, Gong J, Masaki T. Targeting receptor tyrosine kinases in gastric cancer. World J Gastroenterol 2014; 20(16): 4536-4545 [PMID: 24782606 DOI: 10.3748/wjg.v20.i16.4536] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
71 Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer. Tumour Biol 2012;33:1005-14. [PMID: 22278155 DOI: 10.1007/s13277-012-0333-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
72 Lyseng-Williamson KA. Erlotinib : a guide to its use in first-line treatment of non-small-cell lung cancer with epidermal growth factor-activating mutations. Mol Diagn Ther 2013;17:57-62. [PMID: 23334845 DOI: 10.1007/s40291-013-0015-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Seidenstuecker K, van Waes C, Munder BI, Claes KE, Witzel C, Roche N, Stillaert F, Mahajan AL, Andree C, Blondeel PN. DIEAP flap for safe definitive autologous breast reconstruction. The Breast 2016;26:59-66. [DOI: 10.1016/j.breast.2015.12.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
74 Gonzalez CA, Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer. 2010;46:2555-2562. [PMID: 20843485 DOI: 10.1016/j.ejca.2010.07.025] [Cited by in Crossref: 214] [Cited by in F6Publishing: 171] [Article Influence: 19.5] [Reference Citation Analysis]
75 Lee HJ, Jung DB, Sohn EJ, Kim HH, Park MN, Lew JH, Lee SG, Kim B, Kim SH. Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 Cells. Evid Based Complement Alternat Med 2012;2012:390957. [PMID: 23243443 DOI: 10.1155/2012/390957] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
76 Gonçalves IC, Henriques PC, Seabra CL, Martins MCL. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Review of Anti-infective Therapy 2014;12:981-92. [DOI: 10.1586/14787210.2014.930663] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
77 Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia 2012;14:709-18. [PMID: 22952424 DOI: 10.1593/neo.12324] [Cited by in Crossref: 117] [Cited by in F6Publishing: 142] [Article Influence: 13.0] [Reference Citation Analysis]
78 Van Ewijk RJG, Schwentner L, Wöckel A, König J, Kreienberg R, Blettner M; for BRENDA study group. Trends in patient characteristics, treatment and survival in breast cancer in a non-selected retrospective clinical cohort study of 2,600 patients. Arch Gynecol Obstet 2013;287:103-10. [DOI: 10.1007/s00404-012-2544-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
79 Castellano D, Ravaud A, Schmidinger M, De Velasco G, Vazquez F. Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers. Cancer Treat Rev. 2013;39:230-240. [PMID: 22647546 DOI: 10.1016/j.ctrv.2012.04.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
80 Luyckx F, Hallouin P, Barré C, Aillet G, Chauveau P, Hétet JF, Bouchot O, Rigaud J. A new sign for detection of extracapsular extension of prostatic adenocarcinoma: sum of positive sextants per lobe combining interpretation of magnetic resonance imaging and prostate biopsy results. Clin Genitourin Cancer 2013;11:256-62. [PMID: 23830963 DOI: 10.1016/j.clgc.2013.04.034] [Reference Citation Analysis]
81 Ferrís-i-tortajada J, García-i-castell J, Berbel-tornero O, Ortega-garcía J. Constitutional risk factors in prostate cancer. Actas Urológicas Españolas (English Edition) 2011;35:282-8. [DOI: 10.1016/j.acuroe.2011.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am 2015;29:1-27. [PMID: 25475570 DOI: 10.1016/j.hoc.2014.09.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
83 Wu K, Wang X, Xie Z, Liu Z, Lu Y. N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies. J Int Med Res 2013;41:31-7. [PMID: 23569127 DOI: 10.1177/0300060513476988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
84 Li H, Chen C, Wang D. Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway. Mol Med Rep 2018;18:2724-32. [PMID: 30015955 DOI: 10.3892/mmr.2018.9273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Roiss M, Schiffmann J, Tennstedt P, Kessler T, Blanc I, Goetz A, Schlomm T, Graefen M, Reuter DA. Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter? Eur J Surg Oncol 2014;40:1686-92. [PMID: 24613743 DOI: 10.1016/j.ejso.2014.02.223] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
86 Golse N, Adam R. Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results. Clinical Breast Cancer 2017;17:256-65. [DOI: 10.1016/j.clbc.2016.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
87 Eggermont AM. Can immuno-oncology offer a truly pan-tumour approach to therapy? Ann Oncol 2012;23 Suppl 8:viii53-7. [PMID: 22918930 DOI: 10.1093/annonc/mds264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
88 Li F, Xu B, Yang Z, Wu Y, Dong S, Qian J. GSTP1 Ala114Val polymorphism and colorectal cancer risk: a meta-analysis. Tumour Biol 2013;34:1825-31. [PMID: 23504587 DOI: 10.1007/s13277-013-0723-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
89 Pepe P, Aragona F. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology. 2013;81:1142-1146. [PMID: 23726443 DOI: 10.1016/j.urology.2013.02.019] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
90 Palsdottir HB, Hardarson S, Petursdottir V, Jonsson A, Jonsson E, Sigurdsson MI, Einarsson GV, Gudbjartsson T. Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker: Results of a Long-Term, Whole Population Study. Journal of Urology 2012;187:48-53. [DOI: 10.1016/j.juro.2011.09.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
91 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608. [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005] [Cited by in Crossref: 744] [Cited by in F6Publishing: 666] [Article Influence: 82.7] [Reference Citation Analysis]
92 Pernin V, Kirova Y, Campana F. Radiotherapy for breast cancer and erythrokeratodermia variabilis. Cancer Radiother 2014;18:767-9. [PMID: 25306447 DOI: 10.1016/j.canrad.2014.06.026] [Reference Citation Analysis]
93 Lièvre A, Laurent V, Cudennec T, Peschaud F, Malafosse R, Benoist S, Penna C, Lepère C, Vaillant J, Julié C, Teillet L, Nordlinger B, Rougier P, Mitry E. Management of patients over 80 years of age treated with resection for localised colon cancer: Results from a French referral centre. Digestive and Liver Disease 2014;46:838-45. [DOI: 10.1016/j.dld.2014.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
94 Kauntz H, Bousserouel S, Gossé F, Raul F. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Apoptosis 2012;17:797-809. [PMID: 22555452 DOI: 10.1007/s10495-012-0731-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
95 Novell A, Martínez-alonso M, Mira M, Tarragona J, Salud A, Matias-guiu X. Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer. Virchows Arch 2014;464:645-54. [DOI: 10.1007/s00428-014-1572-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
96 Fernández-feito A, Lana A, Cabello-gutiérrez L, Franco-correia S, Baldonedo-cernuda R, Mosteiro-díaz P. Face-to-face Information and Emotional Support from Trained Nurses Reduce Pain During Screening Mammography: Results from a Randomized Controlled Trial. Pain Management Nursing 2015;16:862-70. [DOI: 10.1016/j.pmn.2015.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
97 Braem M, Schouten L, Peeters P, den Brandt PV, Onland-moret N. Genetic susceptibility to sporadic ovarian cancer: A systematic review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011;1816:132-46. [DOI: 10.1016/j.bbcan.2011.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
98 Rolff J, Becker M, Merk J, Hoffmann J, Fichtner I. Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts. Targ Oncol 2016;11:507-14. [DOI: 10.1007/s11523-015-0415-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
99 Wang HF, Yao AL, Sun YY, Zhang AH. Empirically derived dietary patterns and ovarian cancer risk: a meta-analysis. Eur J Cancer Prev 2018;27:493-501. [PMID: 29215374 DOI: 10.1097/CEJ.0000000000000367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
100 Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X, Dong J, Mu MJ, Li X, Wang XH. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology 2014;270:880-7. [PMID: 24475805 DOI: 10.1148/radiol.13130275] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
101 van der Paardt MP, Stoker J. Magnetic Resonance Colonography for Screening and Diagnosis of Colorectal Cancer. Magnetic Resonance Imaging Clinics of North America 2014;22:67-83. [DOI: 10.1016/j.mric.2013.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
102 Bouabdallah S, Sghaier R, Selmi S, Khlifi D, Laouini D, Ben-attia M. Current approaches and challenges for chemical characterization of inhibitory effect against cancer cell line isolated from Gokshur extract. Journal of Chromatography B 2016;1026:279-85. [DOI: 10.1016/j.jchromb.2015.11.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
103 De Leeneer K, Van Bockstal M, De Brouwer S, Swietek N, Schietecatte P, Sabbaghian N, Van den Ende J, Willocx S, Storm K, Blaumeiser B, Van Asperen CJ, Wijnen JT, Leunen K, Legius E, Michils G, Matthijs G, Blok MJ, Gomez-Garcia E, De Paepe A, Tischkowitz M, Poppe B, Claes K. Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing. Breast Cancer Res Treat 2012;133:393-8. [PMID: 22370629 DOI: 10.1007/s10549-012-1998-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
104 Coca-pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz M, Bradford CR, de Bree R, Strojan P, Lund VJ, Mendenhall WM, Nixon IJ, Quer M, Rinaldo A, Ferlito A. Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome. Adv Ther 2018;35:153-60. [DOI: 10.1007/s12325-018-0663-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
105 Delgado-povedano MDM, Calderón-santiago M, Priego-capote F, Jurado-gámez B, Luque de Castro MD. Recent advances in human sweat metabolomics for lung cancer screening. Metabolomics 2016;12. [DOI: 10.1007/s11306-016-1116-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
106 Heng BC, Aubel D, Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 2013;31:1676-94. [DOI: 10.1016/j.biotechadv.2013.08.017] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 11.7] [Reference Citation Analysis]
107 Rigau M, Ortega I, Mir MC, Ballesteros C, Garcia M, Llauradó M, Colás E, Pedrola N, Montes M, Sequeiros T, Ertekin T, Majem B, Planas J, Ruiz A, Abal M, Sánchez A, Morote J, Reventós J, Doll A. A Three-Gene panel on urine increases PSA specificity in the detection of prostate cancer: Urine Assay for the Detection of Prostate Cancer. Prostate 2011;71:1736-45. [DOI: 10.1002/pros.21390] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
108 Pantarotto M, Lombo L, Pereira H, Araújo A. Cutaneous metastasis as the initial manifestation of lung adenocarcinoma. J Bras Pneumol 2011;37:556-9. [PMID: 21881746 DOI: 10.1590/s1806-37132011000400018] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Sternberg CN, Baskin-Bey ES, Watson M, Worsfold A, Rider A, Tombal B. Treatment patterns and characteristics of European patients with castration-resistant prostate cancer. BMC Urol 2013;13:58. [PMID: 24206580 DOI: 10.1186/1471-2490-13-58] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
110 Ludt S, Urban E, Eckardt J, Wache S, Broge B, Kaufmann-Kolle P, Heller G, Miksch A, Glassen K, Hermann K, Bölter R, Ose D, Campbell SM, Wensing M, Szecsenyi J. Evaluating the quality of colorectal cancer care across the interface of healthcare sectors. PLoS One 2013;8:e60947. [PMID: 23658684 DOI: 10.1371/journal.pone.0060947] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
111 Mandel P, Weinhold P, Michl U, Huland H, Graefen M, Tilki D. Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy: Impact of Prostate Volume on Outcomes After Radical Prostatectomy. Prostate 2015;75:1436-46. [DOI: 10.1002/pros.23023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
112 Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol 2015;49:147-54. [PMID: 26029026 DOI: 10.1515/raon-2015-0013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
113 Aglietta M, Barone C, Sawyer MB, Moore MJ, Miller WH, Bagalà C, Colombi F, Cagnazzo C, Gioeni L, Wang E. A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. Ann Oncol. 2014;25:1750-1755. [PMID: 24907635 DOI: 10.1093/annonc/mdu205] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 12.6] [Reference Citation Analysis]
114 Nassar AF, Williams BJ, Yaworksy DC, Patel V, Rusling JF. Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry. Prot Clin Appl 2016;10:280-9. [DOI: 10.1002/prca.201500025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
115 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917. [PMID: 21351269 DOI: 10.1002/ijc.25516] [Cited by in Crossref: 10555] [Cited by in F6Publishing: 9862] [Article Influence: 959.5] [Reference Citation Analysis]
116 Sun Y, Tao C, Yu F, Yang W, Shan Y, Yu Z, Shi H, Zhou M, Zhang Q, Wu H. Discovery of a novel human lactate dehydrogenase A (LDHA) inhibitor as an anti-proliferation agent against MIA PaCa-2 pancreatic cancer cells. RSC Adv 2016;6:23218-22. [DOI: 10.1039/c5ra27736a] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Varlamis I, Apostolakis I, Sifaki-pistolla D, Dey N, Georgoulias V, Lionis C. Application of data mining techniques and data analysis methods to measure cancer morbidity and mortality data in a regional cancer registry: The case of the island of Crete, Greece. Computer Methods and Programs in Biomedicine 2017;145:73-83. [DOI: 10.1016/j.cmpb.2017.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
118 Snoek BC, Wilt LH, Jansen G, Peters GJ. Role of E3 ubiquitin ligases in lung cancer. World J Clin Oncol 2013; 4(3): 58-69 [PMID: 23936758 DOI: 10.5306/wjco.v4.i3.58] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
119 Vickers MM, Powell ED, Asmis TR, Jonker DJ, Hilton JF, O'Callaghan CJ, Tu D, Parulekar W, Moore MJ. Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. Eur J Cancer 2012;48:1434-42. [PMID: 22119354 DOI: 10.1016/j.ejca.2011.10.035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
120 Mavroidis P, Pearlstein KA, Dooley J, Sun J, Saripalli S, Das SK, Wang AZ, Chen RC. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy. Radiat Oncol 2018;13:17. [PMID: 29394931 DOI: 10.1186/s13014-018-0961-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
121 Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G. Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma. Onco Targets Ther 2016;9:2725-33. [PMID: 27226731 DOI: 10.2147/OTT.S75104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
122 Rocha CM, Barros AS, Goodfellow BJ, Carreira IM, Gomes A, Sousa V, Bernardo J, Carvalho L, Gil AM, Duarte IF. NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma. Carcinogenesis 2015;36:68-75. [DOI: 10.1093/carcin/bgu226] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
123 Klatte T, Marberger M. Renal cell carcinoma of native kidneys in renal transplant patients. Current Opinion in Urology 2011;21:376-9. [DOI: 10.1097/mou.0b013e32834962bf] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
124 Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-79. [PMID: 21924589 DOI: 10.1016/j.euroneuro.2011.08.008] [Cited by in Crossref: 918] [Cited by in F6Publishing: 755] [Article Influence: 83.5] [Reference Citation Analysis]
125 Tsitsi T, Charalambous A, Papastavrou E, Raftopoulos V. Effectiveness of a relaxation intervention (progressive muscle relaxation and guided imagery techniques) to reduce anxiety and improve mood of parents of hospitalized children with malignancies: A randomized controlled trial in Republic of Cyprus and Greece. Eur J Oncol Nurs 2017;26:9-18. [PMID: 28069156 DOI: 10.1016/j.ejon.2016.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
126 Mahner S, Eulenburg C, Staehle A, Wegscheider K, Reuss A, Pujade-lauraine E, Harter P, Ray-coquard I, Pfisterer J, du Bois A. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials. European Journal of Cancer 2013;49:142-9. [DOI: 10.1016/j.ejca.2012.07.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
127 Radaelli F, Paggi S, Hassan C, Senore C, Fasoli R, Anderloni A, Buffoli F, Savarese MF, Spinzi G, Rex DK, Repici A. Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme. Gut 2017;66:270-7. [DOI: 10.1136/gutjnl-2015-310685] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 9.6] [Reference Citation Analysis]
128 Moehler M, Mueller A, Trarbach T, Lordick F, Seufferlein T, Kubicka S, Geissler M, Schwarz S, Galle PR, Kanzler S; German Arbeitsgemeinschaft Internistische Onkologie. Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study. Ann Oncol. 2011;22:1358-1366. [PMID: 21119032 DOI: 10.1093/annonc/mdq591] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
129 Arcangeli S, Pinzi V, Arcangeli G. Epidemiology of prostate cancer and treatment remarks. World J Radiol 2012; 4(6): 241-246 [PMID: 22778875 DOI: 10.4329/wjr.v4.i6.241] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
130 Hong J, Kim S, Lin PC. Interleukin-33 and ST2 Signaling in Tumor Microenvironment. J Interferon Cytokine Res 2019;39:61-71. [PMID: 30256696 DOI: 10.1089/jir.2018.0044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
131 Frankel E, Garland S, Meghani SH, Vapiwala N, Mao JJ. Patients' Perspectives on Integrating Acupuncture into the Radiation Oncology Setting. Eur J Integr Med 2014;6:532-7. [PMID: 25386224 DOI: 10.1016/j.eujim.2014.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas Urol Esp 2011;35:501-14. [PMID: 21757259 DOI: 10.1016/j.acuro.2011.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
133 Wu H, Hu J, Liu B, Tao Y, Zhou X, Yuan X. Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility. Tumour Biol 2014;35:3657-62. [PMID: 24318972 DOI: 10.1007/s13277-013-1484-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
134 Colloca G, Venturino A. Anthracycline-based chemotherapy in metastatic endometrial carcinoma: an update. Asia Pac J Clin Oncol 2014;10:e75-85. [PMID: 23176327 DOI: 10.1111/ajco.12016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Yang J, Wang T, Qiu M, Li Q. Comparison of efficacy and toxicity profiles between paclitaxel/lobapoatin- and cisplatin/5-fluorouracil-based concurrent chemoradiotherapy of advanced inoperable oesophageal cancer: Advanced inoperable oesophageal cancer. Intern Med J 2015;45:757-61. [DOI: 10.1111/imj.12773] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
136 Levine J, Petkovska I, Landa J, Bates DDB, Capanu M, Fuqua JL 3rd, Paroder V, Zheng J, Gollub MJ, Pernicka JSG. Bone lesions on baseline staging rectal MRI: prevalence and significance in patients with rectal adenocarcinoma. Abdom Radiol (NY) 2021;46:2423-31. [PMID: 33543320 DOI: 10.1007/s00261-020-02923-7] [Reference Citation Analysis]
137 Karim-kos HE, Kiemeney LA, Louwman MW, Coebergh JWW, de Vries E. Progress against cancer in the Netherlands since the late 1980s: An epidemiological evaluation. Int J Cancer 2012;130:2981-9. [DOI: 10.1002/ijc.26315] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
138 Ock CY, Keam B, Lim Y, Kim TM, Lee SH, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience. Head Neck 2016;38:277-84. [PMID: 26104823 DOI: 10.1002/hed.23891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
139 Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, de Groot K, Stroobants AK, Fockens P, Mundt M, Bossuyt PM, Dekker E. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round. BMC Gastroenterol 2012;12:73. [PMID: 22713100 DOI: 10.1186/1471-230X-12-73] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
140 Qaiser T, Tsang YW, Taniyama D, Sakamoto N, Nakane K, Epstein D, Rajpoot N. Fast and accurate tumor segmentation of histology images using persistent homology and deep convolutional features. Med Image Anal. 2019;55:1-14. [PMID: 30991188 DOI: 10.1016/j.media.2019.03.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 12.3] [Reference Citation Analysis]
141 Syed HA, Talbot N, Abbas A, MacDonald D, Jones R, Marr TJ, Rukin NJ. Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia. J Endourol 2013;27:886-91. [PMID: 23537221 DOI: 10.1089/end.2012.0696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
142 Kirac I, Matošević P, Augustin G, Šimunović I, Hostić V, Župančić S, Hayward C, Antoljak N, Rudan I, Campbell H, Dunlop MG, Velimir Vrdoljak D, Kovačević D, Zgaga L. SMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population. PLoS One 2013;8:e74042. [PMID: 24066093 DOI: 10.1371/journal.pone.0074042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
143 Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. The present and future of prostate cancer urine biomarkers. Int J Mol Sci 2013;14:12620-49. [PMID: 23774836 DOI: 10.3390/ijms140612620] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
144 Li PH, Wang L, Pan YJ, Sang MM, Zheng JN, Pei DS. Suppression of Jab1 expression inhibits proliferation and promotes apoptosis of AMC-HN-8 cells. Oncol Lett 2018;15:5137-42. [PMID: 29552148 DOI: 10.3892/ol.2018.7963] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
145 Salamanna F, Perrone AM, Contartese D, Borsari V, Gasbarrini A, Terzi S, De Iaco P, Fini M. Clinical Characteristics, Treatment Modalities, and Potential Contributing and Prognostic Factors in Patients with Bone Metastases from Gynecological Cancers: A Systematic Review. Diagnostics (Basel) 2021;11:1626. [PMID: 34573970 DOI: 10.3390/diagnostics11091626] [Reference Citation Analysis]
146 Huang BP, Lin CS, Wang CJ, Kao SH. Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2. Int J Med Sci. 2017;14:284-293. [PMID: 28367089 DOI: 10.7150/ijms.17861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
147 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Liska V, Hemminki K. Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers. Clin Epidemiol 2021;13:683-91. [PMID: 34377034 DOI: 10.2147/CLEP.S318737] [Reference Citation Analysis]
148 Peng Q, Lao X, Tang W, Chen Z, Li R, Qin X, Li S. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis. Diagn Pathol. 2014;9:120. [PMID: 24947936 DOI: 10.1186/1746-1596-9-120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
149 Sánchez C, Mercado A, Contreras HR, Mendoza P, Cabezas J, Acevedo C, Huidobro C, Castellón EA. Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins: Drug Sensitivity Recovery in Prostate Cancer. Prostate 2011;71:1810-7. [DOI: 10.1002/pros.21398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
150 Cotruvo JA, Amato H. National Trends of Bladder Cancer and Trihalomethanes in Drinking Water: A Review and Multicountry Ecological Study. Dose Response 2019;17:1559325818807781. [PMID: 30718988 DOI: 10.1177/1559325818807781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
151 Dahle-Smith Å, Stevenson D, Massie D, Murray GI, Dutton SJ, Roberts C, Ferry D, Osborne A, Clark C, Petty RD. Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma. Mol Cytogenet. 2015;8:78. [PMID: 26478746 DOI: 10.1186/s13039-015-0181-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
152 Li L, Luo HS. G-Protein Signaling Protein-17 (RGS17) Is Upregulated and Promotes Tumor Growth and Migration in Human Colorectal Carcinoma. Oncol Res 2018;26:27-35. [PMID: 28337960 DOI: 10.3727/096504017X14900515946914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
153 Lee CS, Ronan L, O'Morain C, McNamara D. Screening for colorectal cancer: what fits best? Expert Rev Gastroenterol Hepatol. 2012;6:301-312. [PMID: 22646253 DOI: 10.1586/egh.12.12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
154 Pretel E, Arias JL, Cabeza L, Melguizo C, Prados J, Mallandrich M, Suñer J, Clares B. Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters. International Journal of Pharmaceutics 2017;530:155-64. [DOI: 10.1016/j.ijpharm.2017.07.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
155 Nyberg M, Ramser K, Lindahl OA. Optical fibre probe NIR Raman measurements in ambient light and in combination with a tactile resonance sensor for possible cancer detection. Analyst 2013;138:4029. [DOI: 10.1039/c3an00243h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
156 Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34:1081-1086. [PMID: 26847337 DOI: 10.1007/s00345-016-1773-y] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 15.3] [Reference Citation Analysis]
157 Ulus T, Yurtseven E, Cavdar S, Erginoz E, Erdogan MS. The suitability of using death certificates as a data source for cancer mortality assessment in Turkey. Croat Med J 2012;53:480-5. [PMID: 23100210 DOI: 10.3325/cmj.2012.53.480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Daudén E, Castañeda S, Suárez C, García-campayo J, Blasco A, Aguilar M, Ferrándiz C, Puig L, Sánchez-carazo J. Abordaje integral de la comorbilidad del paciente con psoriasis. Actas Dermo-Sifiliográficas 2012;103:1-64. [DOI: 10.1016/s0001-7310(12)70001-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
159 Møller H, Sandin F, Robinson D, Bray F, Klint Å, Linklater KM, Lambert PC, Påhlman L, Holmberg L, Morris E. Colorectal cancer survival in socioeconomic groups in England: Variation is mainly in the short term after diagnosis. European Journal of Cancer 2012;48:46-53. [DOI: 10.1016/j.ejca.2011.05.018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
160 Vrdoljak E, Torday L, Sella A, Leyman S, Bavbek S, Kharkevich G, Mardiak J, Szczylik C, Znaor A, Wilking N. Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey. Eur J Cancer Care (Engl) 2015;24:99-110. [PMID: 24661376 DOI: 10.1111/ecc.12149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
161 Obón-santacana M, Slimani N, Lujan-barroso L, Travier N, Hallmans G, Freisling H, Ferrari P, Boutron-ruault M, Racine A, Clavel F, Saieva C, Pala V, Tumino R, Mattiello A, Vineis P, Argüelles M, Ardanaz E, Amiano P, Navarro C, Sánchez M, Molina Montes E, Key T, Khaw K, Wareham N, Peeters P, Trichopoulou A, Bamia C, Trichopoulos D, Boeing H, Kaaks R, Katzke V, Ye W, Sund M, Ericson U, Wirfält E, Overvad K, Tjønneland A, Olsen A, Skeie G, Åsli L, Weiderpass E, Riboli E, Bueno-de-mesquita H, Duell E. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Annals of Oncology 2013;24:2645-51. [DOI: 10.1093/annonc/mdt255] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
162 Wiechno P, Kucharz J, Sadowska M, Michalski W, Sikora-Kupis B, Jonska-Gmyrek J, Poniatowska G, Nietupski K, Ossolinski K, Demkow T. Contemporary treatment of metastatic renal cell carcinoma. Med Oncol 2018;35:156. [PMID: 30368624 DOI: 10.1007/s12032-018-1217-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
163 Leitzmann MF, Rohrmann S. Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol 2012;4:1-11. [PMID: 22291478 DOI: 10.2147/CLEP.S16747] [Cited by in Crossref: 120] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
164 Petrusca L, Salomir R, Manasseh G, Becker CD, Terraz S. Spatio-temporal quantitative thermography of pre-focal interactions between high intensity focused ultrasound and the rib cage. Int J Hyperthermia 2015;31:421-32. [PMID: 25753370 DOI: 10.3109/02656736.2015.1009501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
165 Bastani P, Kiadaliri AA. Cost-utility analysis of adjuvant therapies for breast cancer in Iran. Int J Technol Assess Health Care 2012;28:110-4. [PMID: 22559752 DOI: 10.1017/S0266462312000049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
166 Georgiadou D, Sergentanis TN, Sakellariou S, Vlachodimitropoulos D, Psaltopoulou T, Lazaris AC, Gounaris A, Zografos GC. Prognostic role of sex steroid receptors in pancreatic adenocarcinoma. Pathol Res Pract. 2016;212:38-43. [PMID: 26652605 DOI: 10.1016/j.prp.2015.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
167 Hadji P, Ziller V, Kyvernitakis J, Bauer M, Haas G, Schmidt N, Kostev K. Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis. Breast Cancer Res Treat 2013;138:185-91. [PMID: 23334803 DOI: 10.1007/s10549-013-2417-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
168 Colloca G. Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: a review. Cancer Treat Rev. 2012;38:1020-1026. [PMID: 22503300 DOI: 10.1016/j.ctrv.2012.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
169 van Jaarsveld MT, Blijdorp IC, Boersma AW, Pothof J, Mathijssen RH, Verweij J, Wiemer EA. The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin. Eur J Cancer 2013;49:345-51. [PMID: 23041051 DOI: 10.1016/j.ejca.2012.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
170 Chen D, Li Y, Wang L, Jiao K. SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma. Int J Breast Cancer 2015;2015:539721. [PMID: 25973277 DOI: 10.1155/2015/539721] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
171 Pinto F, Totaro A, Palermo G, Calarco A, Sacco E, D’Addessi A, Racioppi M, Valentini A, Gui B, Bassi P. Imaging in prostate cancer staging: present role and future perspectives. Urol Int. 2012;88:125-136. [PMID: 22286304 DOI: 10.1159/000335205] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
172 Shafique K, Proctor MJ, McMillan DC, Qureshi K, Leung H, Morrison DS. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study. Prostate Cancer Prostatic Dis 2012;15:195-201. [PMID: 22343838 DOI: 10.1038/pcan.2011.60] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
173 Colloca G, Venturino A, Guarneri D. Tumor Growth Kinetics Before and After First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: A Prostate-specific Antigen-based Retrospective Analysis. Am J Clin Oncol 2018;41:316-20. [PMID: 26886944 DOI: 10.1097/COC.0000000000000270] [Reference Citation Analysis]
174 Colloca G, Venturino A, Governato I, Checcaglini F. Incidence and Correlates of Fatigue in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review. Clinical Genitourinary Cancer 2016;14:5-11. [DOI: 10.1016/j.clgc.2015.07.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
175 Derakhshan MK, Karbassian MH. Psychiatric and Psychosocial Aspects of Breast Cancer Diagnoses and Treatments. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 45-77. [DOI: 10.1007/978-3-319-64550-6_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
176 Mehnert A, Koch U, Schulz H, Wegscheider K, Weis J, Faller H, Keller M, Brähler E, Härter M. Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients - study protocol of an epidemiological multi-center study. BMC Psychiatry 2012;12:70. [PMID: 22747671 DOI: 10.1186/1471-244X-12-70] [Cited by in Crossref: 56] [Cited by in F6Publishing: 15] [Article Influence: 5.6] [Reference Citation Analysis]
177 Kimbara S, Kondo S. Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016; 22(33): 7440-7452 [PMID: 27672267 DOI: 10.3748/wjg.v22.i33.7440] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
178 García-foncillas J, Garrido P, Gómez J, Palacios J, Tarón M. Recomendaciones para la determinación de las mutaciones del gen EGFR en el carcinoma de pulmón no microcítico. Revista Española de Patología 2011;44:17-31. [DOI: 10.1016/j.patol.2011.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Kurzawa-Zegota M, Najafzadeh M, Baumgartner A, Anderson D. The protective effect of the flavonoids on food-mutagen-induced DNA damage in peripheral blood lymphocytes from colon cancer patients. Food Chem Toxicol 2012;50:124-9. [PMID: 21907754 DOI: 10.1016/j.fct.2011.08.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
180 Núñez-Rodríguez H, Diez-Redondo P, Pérez-Miranda M, Gonzalez Sagrado M, Conde R, De la Serna C. Role of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Trial. J Clin Gastroenterol 2019;53:191-6. [PMID: 29283904 DOI: 10.1097/MCG.0000000000000975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
181 Usychkin S, Calvo F, dos Santos MA, Samblás J, de Urbina DO, Bustos JC, Diaz JA, Sallabanda K, Sanz A, Yélamos C, Peraza C, Delgado JM, Marsiglia H. Intra-operative electron beam radiotherapy for newly diagnosed and recurrent malignant gliomas: feasibility and long-term outcomes. Clin Transl Oncol 2013;15:33-8. [PMID: 22855176 DOI: 10.1007/s12094-012-0892-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
182 Ghebriou D, Avenin D, Caillet P, Mongiat-artus P, Durdux C, Massard C, Culine S. Mise au point du FRancilian Oncogeriatric Group (FROG) pour la prise en charge du cancer de vessie du sujet âgé. Bulletin du Cancer 2014;101:841-55. [DOI: 10.1684/bdc.2014.1939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
183 Cianni R, Pelle G. Evidence-based integration of selective internal radiation therapy into the management of breast cancer liver metastases. Future Oncology 2014;10:93-5. [DOI: 10.2217/fon.14.233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
184 Dalla Palma M, Gregianin M, Fiduccia P, Evangelista L, Cervino AR, Saladini G, Borgato L, Nicoletto MO, Zagonel V. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis. Crit Rev Oncol Hematol 2012;83:84-98. [PMID: 22245509 DOI: 10.1016/j.critrevonc.2011.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
185 Nittka S, Krueger MA, Shively JE, Boll H, Brockmann MA, Doyon F, Pichler BJ, Neumaier M. Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice. PLoS One. 2014;9:e106921. [PMID: 25226518 DOI: 10.1371/journal.pone.0106921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
186 Hoff G. Different standards for healthy screenees than patients in routine clinics? World J Gastroenterol 2013; 19(46): 8527-8530 [PMID: 24379569 DOI: 10.3748/wjg.v19.i46.8527] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
187 Pericleous P, Gazouli M, Lyberopoulou A, Rizos S, Nikiteas N, Efstathopoulos EP. Detection of colorectal circulating cancer cells with the use of a quantum dot labelled magnetic immunoassay method. Hellenic J Surg 2013;85:127-34. [DOI: 10.1007/s13126-013-0025-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
188 Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Asatryan L, Wirth MP, Siegert G. Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases. Inflamm Res 2013;62:1063-72. [DOI: 10.1007/s00011-013-0665-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
189 Maschio M, Aguglia U, Avanzini G, Banfi P, Buttinelli C, Capovilla G, Casazza MML, Colicchio G, Coppola A, Costa C, Dainese F, Daniele O, De Simone R, Eoli M, Gasparini S, Giallonardo AT, La Neve A, Maialetti A, Mecarelli O, Melis M, Michelucci R, Paladin F, Pauletto G, Piccioli M, Quadri S, Ranzato F, Rossi R, Salmaggi A, Terenzi R, Tisei P, Villani F, Vitali P, Vivalda LC, Zaccara G, Zarabla A, Beghi E; Brain Tumor-related Epilepsy study group of Italian League Against Epilepsy (LICE). Management of epilepsy in brain tumors. Neurol Sci 2019;40:2217-34. [PMID: 31392641 DOI: 10.1007/s10072-019-04025-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
190 Shokri A, Mahanpoor K. Degradation of ortho-toluidine from aqueous solution by the TiO2/O3 process. Int J Ind Chem 2017;8:101-8. [DOI: 10.1007/s40090-016-0110-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
191 Leuraud K, Jezewski-Serra D, Viguier J, Salines E. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol. 2013;37:959-967. [PMID: 24035240 DOI: 10.1016/j.canep.2013.07.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
192 Hungr N, Long JA, Beix V, Troccaz J. A realistic deformable prostate phantom for multimodal imaging and needle-insertion procedures. Med Phys 2012;39:2031-41. [PMID: 22482624 DOI: 10.1118/1.3692179] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
193 Maffione AM, Rubello D, Caroli P, Colletti PM, Matteucci F. Is It Time to Introduce PET/CT in Colon Cancer Guidelines? Clin Nucl Med 2020;45:525-30. [PMID: 32433179 DOI: 10.1097/RLU.0000000000003076] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Shokri A, Mahanpoor K, Soodbar D. Degradation of Ortho-Toluidine in petrochemical wastewater by ozonation, UV/O 3 , O 3 /H 2 O 2 and UV/O 3 /H 2 O 2 processes. Desalination and Water Treatment 2015;57:16473-82. [DOI: 10.1080/19443994.2015.1085454] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
195 Eide ML, Debaque H. HPV detection methods and genotyping techniques in screening for cervical cancer. Ann Pathol 2012;32:e15-23, 401-9. [PMID: 23244480 DOI: 10.1016/j.annpat.2012.09.231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
196 Meissnitzer M, Forstner R. [Radiological diagnostics of ovarian cancer]. Radiologe 2011;51:581-8. [PMID: 21559924 DOI: 10.1007/s00117-010-2120-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
197 Campa D, Pardini B, Naccarati A, Vodickova L, Novotny J, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Kötting J, Betz B, Kloor M, Engel C, Büttner R, Propping P, Försti A, Hemminki K, Barale R, Vodicka P, Canzian F. Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study. BMC Gastroenterol 2010;10:112. [PMID: 20920174 DOI: 10.1186/1471-230X-10-112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
198 Morales R, Font A, Carles J, Isla D. SEOM clinical guidelines for the treatment of invasive bladder cancer. Clin Transl Oncol 2011;13:552-9. [DOI: 10.1007/s12094-011-0696-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
199 van de Loo JW, Trzaska D, Berkouk K, Vidal M, Draghia-Akli R. Emphasising the European Union's Commitment to Cancer Research: a helicopter view of the Seventh Framework Programme for Research and Technological Development. Oncologist 2012;17:e26-32. [PMID: 23104172 DOI: 10.1634/theoncologist.2012-0327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
200 Teghom C, Gachet J, Scotté F, Elaidi R, Oudard S. [Bellini tumours]. Bull Cancer 2011;98:1230-2. [PMID: 22001860 DOI: 10.1684/bdc.2011.1462] [Reference Citation Analysis]
201 Babakhani F, Azad TM, Kondori N, Jalilvand S, Mozhgani S, Ghavami N, Farzanehpour M, Babaei F. Detection of HPV genotypes and their association with p53 codon 72 polymorphism in prostate cancer. Future Virology 2017;12:275-81. [DOI: 10.2217/fvl-2017-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
202 Pan SY, Morrison H. Physical activity and hematologic cancer prevention. Recent Results Cancer Res 2011;186:135-58. [PMID: 21113763 DOI: 10.1007/978-3-642-04231-7_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
203 Altwegg R, Ychou M, Guillaumon V, Thezenas S, Senesse P, Flori N, Mazard T, Caillo L, Faure S, Samalin E, Assenat E. Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer. World J Gastroenterol 2012; 18(12): 1357-1364 [PMID: 22493549 DOI: 10.3748/wjg.v18.i12.1357] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
204 Fan H, Zhu JH, Yao XQ. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Mol Med Rep 2018;17:8309-15. [PMID: 29693171 DOI: 10.3892/mmr.2018.8907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
205 Krijgsman D, De Vries NL, Andersen MN, Skovbo A, Tollenaar RAEM, Bastiaannet E, Kuppen PJK, Hokland M. The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma. Cancer Immunol Immunother 2020;69:2009-20. [PMID: 32399587 DOI: 10.1007/s00262-020-02590-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Xiang HP, Geng XP, Ge WW, Li H. Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility. Eur J Cancer 2011;47:2546-51. [PMID: 21807500 DOI: 10.1016/j.ejca.2011.03.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
207 Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. Eur J Cancer 2011;47:1571-7. [PMID: 21367600 DOI: 10.1016/j.ejca.2011.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
208 Sun H, Chang Q, Liu YS, Jiang YT, Gong TT, Ma XX, Zhao YH, Wu QJ. Adherence to Cancer Prevention Guidelines and Endometrial Cancer Risk: Evidence from a Systematic Review and Dose-Response Meta-analysis of Prospective Studies. Cancer Res Treat 2021;53:223-32. [PMID: 32972048 DOI: 10.4143/crt.2020.546] [Reference Citation Analysis]
209 Liu C, Wen Z, Li Y, Peng L. Application of ThinPrep bronchial brushing cytology in the early diagnosis of lung cancer: a retrospective study. PLoS One 2014;9:e90163. [PMID: 24759600 DOI: 10.1371/journal.pone.0090163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
210 Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J, Cao HY. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res. 2012;40:2041-2050. [PMID: 23321160 DOI: 10.1177/030006051204000601] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 9.1] [Reference Citation Analysis]
211 Miklavčič D, Serša G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG, Jarm T. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012;50:1213-25. [PMID: 23179413 DOI: 10.1007/s11517-012-0991-8] [Cited by in Crossref: 138] [Cited by in F6Publishing: 111] [Article Influence: 13.8] [Reference Citation Analysis]
212 Colloca G, Colloca P. The Effects of Social Support on Health-Related Quality of Life of Patients with Metastatic Prostate Cancer. J Cancer Educ 2016;31:244-52. [PMID: 26174117 DOI: 10.1007/s13187-015-0884-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
213 Assis J, Pereira D, Medeiros R. Ovarian cancer and DNA repair: DNA ligase IV as a potential key. World J Clin Oncol 2013; 4(1): 14-24 [PMID: 23538968 DOI: 10.5306/wjco.v4.i1.14] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
214 Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 2010;102:1384-90. [PMID: 20424616 DOI: 10.1038/sj.bjc.6605654] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
215 Wadhwa K, Carmona-Echeveria L, Kuru T, Gaziev G, Serrao E, Parashar D, Frey J, Dimov I, Seidenader J, Acher P, Muir G, Doble A, Gnanapragasam V, Hadaschik B, Kastner C. Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures. Asian J Androl 2017;19:62-6. [PMID: 26924279 DOI: 10.4103/1008-682X.173453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
216 Van Effelterre T, Hogea C, Taylor S. Projected impact of Cervarix® vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom. Hum Vaccin Immunother 2014;10:1794. [PMID: 25424784 DOI: 10.4161/hv.28834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
217 Zokalj I, Marotti M, Kolarić B. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches. Int Urol Nephrol 2014;46:1089-100. [PMID: 24381132 DOI: 10.1007/s11255-013-0631-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
218 Perisanidis C, Kornek G, Pöschl PW, Holzinger D, Pirklbauer K, Schopper C, Ewers R. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0334-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
219 Bolla M, Verry C, Giraud J, Long J, Conil M, Abidi R, Troccaz J, Colonna M, Descotes J. Results of a cohort of 200 hormone-naïve consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team. Cancer/Radiothérapie 2014;18:643-8. [DOI: 10.1016/j.canrad.2014.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
220 Cadron I, Abdulkadir L, Despierre E, Berteloot P, Neven P, Leunen K, Amant F, Vergote I. The “Leuven” paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study. Gynecologic Oncology 2013;128:34-7. [DOI: 10.1016/j.ygyno.2012.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
221 Van't Westeinde SC, van Klaveren RJ. Screening and early detection of lung cancer. Cancer J 2011;17:3-10. [PMID: 21263260 DOI: 10.1097/PPO.0b013e3182099319] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
222 Hureaux J, Couturier O, Lacœuille F, Bouchet F, Chouaïd C, Saulnier P, Urban T; les investigateurs du projet. [Can positron emission tomography assessment of response to treatment help to individualize use of erlotinib in non-small cell lung cancer?]. Rev Mal Respir 2016;33:817-23. [PMID: 27257103 DOI: 10.1016/j.rmr.2016.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
223 Corten BJGA, Alexander S, van Zwam PH, Leclercq WKG, Roumen RMH, Slooter GD. Outcome of Surgical Inspection of the Gallbladder in Relation to Final Pathology. J Gastrointest Surg 2019;23:1130-4. [DOI: 10.1007/s11605-018-3921-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
224 Aladowicz E, Ferro L, Vitali GC, Venditti E, Fornasari L, Lanfrancone L. Molecular networks in melanoma invasion and metastasis. Future Oncol 2013;9:713-26. [PMID: 23647299 DOI: 10.2217/fon.13.9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
225 Lekka M, Gil D, Pogoda K, Dulińska-Litewka J, Jach R, Gostek J, Klymenko O, Prauzner-Bechcicki S, Stachura Z, Wiltowska-Zuber J, Okoń K, Laidler P. Cancer cell detection in tissue sections using AFM. Arch Biochem Biophys 2012;518:151-6. [PMID: 22209753 DOI: 10.1016/j.abb.2011.12.013] [Cited by in Crossref: 204] [Cited by in F6Publishing: 172] [Article Influence: 18.5] [Reference Citation Analysis]
226 Ye XT, Guo AJ, Yin PF, Cao XD, Chang JC. Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer. Med Oncol. 2014;31:61. [PMID: 24943992 DOI: 10.1007/s12032-014-0061-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
227 Gomes MA, Priolli DG, Tralhão JG, Botelho MF. Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies. Rev Assoc Med Bras (1992) 2013;59:514-24. [PMID: 24041910 DOI: 10.1016/j.ramb.2013.03.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
228 Ezendam NP, Nicolaije KA, Boll D, Lybeert ML, Mols F, Pijnenborg JM, van de Poll-franse LV. Health Care Use Among Endometrial Cancer Survivors: A Study From PROFILES, a Population-Based Survivorship Registry. Int J Gynecol Cancer 2013;23:1258-65. [DOI: 10.1097/igc.0b013e31829dd1e3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
229 Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, Holleczek B, Tryggvadóttir L, Comber H, Bento MJ, Diba ChS, Micallef R, Primic-Žakelj M, Izarzugaza MI, Perucha J, Marcos-Gragera R, Galceran J, Ardanaz E, Schaffar R, Pring A, de Vries E. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol 2014;28:1170-8. [PMID: 23962170 DOI: 10.1111/jdv.12236] [Cited by in Crossref: 128] [Cited by in F6Publishing: 121] [Article Influence: 14.2] [Reference Citation Analysis]
230 Metro G, Crinò L. Advances on EGFR mutation for lung cancer. Transl Lung Cancer Res 2012;1:5-13. [PMID: 25806150 DOI: 10.3978/j.issn.2218-6751.2011.12.01] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
231 Kósa JP, Horváth P, Wölfling J, Kovács D, Balla B, Mátyus P, Horváth E, Speer G, Takács I, Nagy Z, Horváth H, Lakatos P. CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. World J Gastroenterol 2013; 19(17): 2621-2628 [PMID: 23674869 DOI: 10.3748/wjg.v19.i17.2621] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
232 Kim R, Ock CY, Keam B, Kim TM, Kim JH, Paeng JC, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS. Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study. BMC Cancer 2016;16:116. [PMID: 26884055 DOI: 10.1186/s12885-016-2147-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
233 Martín Sánchez V, Muinelo Voces MI, Jorquera Plaza F, Molina De La Torre AJ, De Abajo Olea S, Tamames Gómez S, López-abente G. Tendencia y distribución municipal de la incidencia de cáncer colorrectal en el área de salud de León (1994-2008). Gastroenterología y Hepatología 2012;35:299-308. [DOI: 10.1016/j.gastrohep.2012.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Wang L, Chang Y, Xu J, Zhang Q. Predictive Significance of Serum Level of Vascular Endothelial Growth Factor in Gastric Cancer Patients. Biomed Res Int 2016;2016:8103019. [PMID: 27597973 DOI: 10.1155/2016/8103019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
235 Fan T, Wang W, Zhang B, Xu Y, Chen L, Pan S, Hu H, Geng Q. Regulatory mechanisms of microRNAs in lung cancer stem cells. Springerplus 2016;5:1762. [PMID: 27795904 DOI: 10.1186/s40064-016-3425-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
236 Friemel J, Foraita R, Günther K, Heibeck M, Günther F, Pflueger M, Pohlabeln H, Behrens T, Bullerdiek J, Nimzyk R, Ahrens W. Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients. BMC Oral Health 2016;16:33. [PMID: 26969620 DOI: 10.1186/s12903-016-0185-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
237 Stranjalis G, Kalamatianos T, Stavrinou LC, Mathios D, Koutsarnakis C, Tzavara C, Loufardaki M, Protopappa D, Argyrakos T, Rontogianni DP, Sakas DE. The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009). Surg Neurol Int 2013;4:23. [PMID: 23533006 DOI: 10.4103/2152-7806.107893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
238 Moliner L, González AJ, Soriano A, Sánchez F, Correcher C, Orero A, Carles M, Vidal LF, Barberá J, Caballero L, Seimetz M, Vázquez C, Benlloch JM. Design and evaluation of the MAMMI dedicated breast PET: Design and evaluation of the MAMMI dedicated breast PET. Med Phys 2012;39:5393-404. [DOI: 10.1118/1.4742850] [Cited by in Crossref: 77] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
239 Mardjuadi F, Medioni J, Kerger J, D'Hondt L, Canon JL, Duck L, Musuamba F, Oudard S, Clausse M, Moxhon A, Machiels JP. Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol 2012;70:293-303. [PMID: 22752248 DOI: 10.1007/s00280-012-1914-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
240 Allegra E, Caltabiano R, Amorosi A, Vasquez E, Garozzo A, Puzzo L. Expression of BMI1 and p16 in laryngeal squamous cell carcinoma. Head Neck 2013;35:847-51. [PMID: 22730165 DOI: 10.1002/hed.23042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
241 Chen X, Sun L, Mao Y, Zhu S, Wu J, Huang O, Li Y, Chen W, Wang J, Yuan Y, Fei X, Jin X, Shen K. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer 2013;13:390. [PMID: 23957561 DOI: 10.1186/1471-2407-13-390] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
242 Rogler A, Kendziorra E, Giedl J, Stoehr C, Taubert H, Goebell PJ, Wullich B, Stöckle M, Lehmann J, Petsch S, Hartmann A, Stoehr R. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. J Cancer Res Clin Oncol 2015;141:1779-90. [DOI: 10.1007/s00432-015-1942-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
243 Caffo O, Ortega C, Di Lorenzo G, Sava T, De Giorgi U, Cavaliere C, Macrini S, Spizzo G, Aieta M, Messina C, Tucci M, Lodde M, Mansueto G, Zucali PA, Alesini D, D'Angelo A, Massari F, Morelli F, Procopio G, Ratta R, Fratino L, Lo Re G, Pegoraro MC, Zustovich F, Vicario G, Ruatta F, Federico P, La Russa F, Burgio SL, Maines F, Veccia A, Galligioni E. Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger. Urol Oncol 2015;33:265.e15-21. [PMID: 25907622 DOI: 10.1016/j.urolonc.2015.02.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
244 Kelly E, Stephens P. Cancer in the older person. Rev Clin Gerontol 2015;25:172-80. [DOI: 10.1017/s0959259815000131] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
245 Le Fur E, Malhaire J, Baverez D, Delage F, Perrouin-verbe M, Schlurmann F, Guerif S, Fournier G, Pradier O, Valeri A. Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer. Strahlenther Onkol 2012;188:1091-5. [DOI: 10.1007/s00066-012-0242-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
246 Rotondano G, Bianco MA, Sansone S, Prisco A, Meucci C, Garofano ML, Cipolletta L. Trimodal endoscopic imaging for the detection and differentiation of colorectal adenomas: a prospective single-centre clinical evaluation. Int J Colorectal Dis. 2012;27:331-336. [PMID: 21904833 DOI: 10.1007/s00384-011-1312-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
247 Roelants M, Van Cleynenbreugel B, Van Poppel H, Lerut E, de Witte PA. Use of fluorescein isothiocyanate-human serum albumin for the intravesical photodiagnosis of non-muscle-invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell lines. BJU Int 2011;108:455-9. [PMID: 21156021 DOI: 10.1111/j.1464-410X.2010.09951.x] [Reference Citation Analysis]
248 Chuang SC, Stolzenberg-Solomon R, Ueland PM, Vollset SE, Midttun Ø, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault MC, Morois S. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer. 2011;47:1808-1816. [PMID: 21411310 DOI: 10.1016/j.ejca.2011.02.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
249 Zijlstra C, Stoorvogel W. Prostasomes as a source of diagnostic biomarkers for prostate cancer. J Clin Invest 2016;126:1144-51. [PMID: 27035806 DOI: 10.1172/JCI81128] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
250 Muñoz García-borruel M, Hervás Molina AJ, Rodríguez Perálvarez ML, Moreno Rincón E, Pérez Medrano I, Serrano Ruiz FJ, Casáis Juanena LL, Pleguezuelo Navarro M, Naranjo Rodríguez A, Villar Pastor C. Cáncer colorrectal poscolonoscopia: características y factores predictivos. Medicina Clínica 2018;150:1-7. [DOI: 10.1016/j.medcli.2017.04.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Egerdie RB, Saad F, Smith MR, Tammela TL, Heracek J, Sieber P, Ke C, Leder B, Dansey R, Goessl C. Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2012;15:308-312. [PMID: 22641239 DOI: 10.1038/pcan.2012.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
252 Ortiz-Oshiro E, Sánchez-Egido I, Moreno-Sierra J, Pérez CF, Díaz JS, Fernández-Represa JÁ. Robotic assistance may reduce conversion to open in rectal carcinoma laparoscopic surgery: systematic review and meta-analysis. Int J Med Robot. 2012;8:360-370. [PMID: 22438060 DOI: 10.1002/rcs.1426] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
253 Eckstein N, Haas B. Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer. Eur J Clin Pharmacol 2014;70:791-8. [PMID: 24756149 DOI: 10.1007/s00228-014-1682-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
254 Majidzadeh-a K, Kaviani A, Esmaeili R, Farahmand L, Shojamoradi MH, Zare AA, Eini L, Abbasvandi F, Olfatbakhsh A, Moazen H. Iranian Breast Cancer Bio-Bank: the activity and challenging issues. Cell Tissue Bank 2013;14:11-20. [DOI: 10.1007/s10561-012-9293-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
255 de Lima MM, Filho SSJ, Tobias-Machado M. Association between PSA and age in Macuxi ethnic population of the Brazilian Amazon forest region. Res Rep Urol 2018;10:159-68. [PMID: 30349813 DOI: 10.2147/RRU.S149836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
256 Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C; English Bowel Cancer Screening Evaluation Committee. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61:1439-46. [PMID: 22156981 DOI: 10.1136/gutjnl-2011-300843] [Cited by in Crossref: 308] [Cited by in F6Publishing: 273] [Article Influence: 28.0] [Reference Citation Analysis]
257 Gonnissen A, Isebaert S, Haustermans K. Hedgehog signaling in prostate cancer and its therapeutic implication. Int J Mol Sci 2013;14:13979-4007. [PMID: 23880852 DOI: 10.3390/ijms140713979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
258 Andrealli A, Paggi S, Amato A, Rondonotti E, Imperiali G, Lenoci N, Mandelli G, Terreni N, Spinzi G, Radaelli F. Educational strategies for colonoscopy bowel prep overcome barriers against split-dosing: A randomized controlled trial. United European Gastroenterol J 2018;6:283-9. [PMID: 29511558 DOI: 10.1177/2050640617717157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
259 Hoogendoorn M, Moons LMG, Numans ME, Sips R. Utilizing Data Mining for Predictive Modeling of Colorectal Cancer Using Electronic Medical Records. In: Ślȩzak D, Tan A, Peters JF, Schwabe L, editors. Brain Informatics and Health. Cham: Springer International Publishing; 2014. pp. 132-41. [DOI: 10.1007/978-3-319-09891-3_13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
260 Chekerov R, Braicu I, Castillo-tong DC, Richter R, Cadron I, Mahner S, Woelber L, Marth C, Van Gorp T, Speiser P, Zeillinger R, Vergote I, Sehouli J. Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD: . International Journal of Gynecological Cancer 2013;23:268-75. [DOI: 10.1097/igc.0b013e31827de6b9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
261 Galilea San Blas O, Moreno Sanz F, Herrero Espílez P, Sainz Menéndez RM, Mayo Barallo JC, Marchante-Gayón JM, García Alonso JI. Evaluation of sulfur isotopic enrichment of urine metabolites for the differentiation of healthy and prostate cancer mice after the administration of 34S labelled yeast. J Trace Elem Med Biol 2017;39:155-61. [PMID: 27908409 DOI: 10.1016/j.jtemb.2016.09.006] [Reference Citation Analysis]
262 Sarigiannis DA, Handakas EJ, Karakitsios SP, Gotti A. Life cycle assessment of municipal waste management options. Environ Res 2021;193:110307. [PMID: 33065069 DOI: 10.1016/j.envres.2020.110307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
263 Sreekumar R, Harris S, Moutasim K, DeMateos R, Patel A, Emo K, White S, Yagci T, Tulchinsky E, Thomas G, Primrose JN, Sayan AE, Mirnezami AH. Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification. JAMA Netw Open 2018;1:e183115. [PMID: 30646224 DOI: 10.1001/jamanetworkopen.2018.3115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
264 Bullock MD, Pickard KM, Nielsen BS, Sayan AE, Jenei V, Mellone M, Mitter R, Primrose JN, Thomas GJ, Packham GK. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis. 2013;4:e684. [PMID: 23788041 DOI: 10.1038/cddis.2013.213] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
265 Izumi K, Li L, Chang C. Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer. Clin Investig (Lond) 2014;4:935-50. [PMID: 26594314 DOI: 10.4155/cli.14.77] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
266 Climent MA, Anido U, Méndez-Vidal MJ, Puente J. Zoledronic acid in genitourinary cancer. Clin Transl Oncol 2013;15:871-8. [PMID: 23615978 DOI: 10.1007/s12094-013-1033-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
267 Patel V, Sproat C, Kwok J, Tanna N. Axitinib-related osteonecrosis of the jaw. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2017;124:e257-60. [DOI: 10.1016/j.oooo.2017.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
268 Nozawa H, Kitayama J, Sunami E, Watanabe T. Impact of chronic kidney disease on outcomes of surgical resection for primary colorectal cancer: a retrospective cohort review. Dis Colon Rectum 2012;55:948-56. [PMID: 22874601 DOI: 10.1097/DCR.0b013e3182600db7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
269 Missinne S, Bracke P. A cross-national comparative study on the influence of individual life course factors on mammography screening. Health Policy 2015;119:709-19. [PMID: 25921692 DOI: 10.1016/j.healthpol.2015.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
270 Hrbáček J, Minárik I, Sieger T, Babjuk M. External validation of extended prostate biopsy nomogram. Cent European J Urol 2015;68:148-52. [PMID: 26251732 DOI: 10.5173/ceju.2015.610] [Reference Citation Analysis]
271 Pepe P, Aragona F. Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center. World J Urol 2014;32:373-7. [DOI: 10.1007/s00345-013-1108-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
272 Gravina GL, Mancini A, Muzi P, Ventura L, Biordi L, Ricevuto E, Pompili S, Mattei C, Di Cesare E, Jannini EA, Festuccia C. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models. Prostate 2015;75:1227-46. [PMID: 26073897 DOI: 10.1002/pros.23007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
273 Rawłuszko AA, Horbacka K, Krokowicz P, Jagodziński PP. Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon. BMC Cancer 2011;11:522. [PMID: 22176788 DOI: 10.1186/1471-2407-11-522] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
274 Tralongo P, Annunziata MA, Santoro A, Tirelli U, Surbone A. Beyond Semantics: The Need to Better Categorize Patients With Cancer. JCO 2013;31:2637-8. [DOI: 10.1200/jco.2013.50.0850] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
275 Oudard S. Progress in emerging therapies for advanced prostate cancer. Cancer Treat Rev 2013;39:275-89. [PMID: 23107383 DOI: 10.1016/j.ctrv.2012.09.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
276 O'Brien ME, Konopa K, Lorigan P, Bosquee L, Marshall E, Bustin F, Margerit S, Fink C, Stigt JA, Dingemans AM, Hasan B, Van Meerbeeck J, Baas P. Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062. Eur J Cancer 2011;47:2322-30. [PMID: 21684151 DOI: 10.1016/j.ejca.2011.05.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
277 Sang H, Zhang L, Li J. Anti-benzopyrene-7,8-diol-9,10-epoxide induces apoptosis via mitochondrial pathway in human bronchiolar epithelium cells independent of the mitochondria permeability transition pore. Food and Chemical Toxicology 2012;50:2417-23. [DOI: 10.1016/j.fct.2012.04.041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
278 Nikolaev S, Cotin S. Estimation of boundary conditions for patient-specific liver simulation during augmented surgery. Int J Comput Assist Radiol Surg 2020;15:1107-15. [PMID: 32451816 DOI: 10.1007/s11548-020-02188-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
279 Cooter M, Soliman AS, Pavlou P, Demetriou A, Orphanides C, Kritioti E, Banerjee M, Farazi PA. Incidence and time trends of cancer in Cyprus over 11 years (1998-2008). Tumori 2015;101:8-15. [PMID: 25702662 DOI: 10.5301/tj.5000204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
280 Findlay JM, Middleton MR, Tomlinson I. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Ann Oncol. 2015;26:624-644. [PMID: 25214541 DOI: 10.1093/annonc/mdu449] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
281 Hanprasertpong J, Fujiwara K. Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review: Splenectomy for ovarian cancer cytoreduction. European Journal of Cancer Care 2011;20:287-93. [DOI: 10.1111/j.1365-2354.2010.01224.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
282 Bussu F, Sali M, Gallus R, Vellone VG, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R, Graziani C, Miccichè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Valentini V, Paludetti G. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer 2013;108:1157-62. [PMID: 23403821 DOI: 10.1038/bjc.2013.55] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
283 Gohil R, Rishi M, Tan BH. Pre-operative serum albumin and neutrophil-lymphocyte ratio are associated with prolonged hospital stay following colorectal cancer surgery. Br J Med Med Res 2014;4:481-7. [PMID: 24278850 DOI: 10.9734/BJMMR/2014/5444#sthash.FpqnVF8X.dpuf] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
284 Brown EM, Allsopp PJ, Magee PJ, Gill CI, Nitecki S, Strain CR, Mcsorley EM. Seaweed and human health. Nutr Rev 2014;72:205-16. [DOI: 10.1111/nure.12091] [Cited by in Crossref: 166] [Cited by in F6Publishing: 125] [Article Influence: 20.8] [Reference Citation Analysis]
285 Saarimäki L, Tammela TL, Määttänen L, Taari K, Kujala PM, Raitanen J, Auvinen A. Family history in the Finnish Prostate Cancer Screening Trial: Impact of FH on outcomes of PC screening. Int J Cancer 2015;136:2172-7. [DOI: 10.1002/ijc.29243] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
286 Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway. J Cancer Res Clin Oncol 2015;141:431-41. [PMID: 25245053 DOI: 10.1007/s00432-014-1836-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
287 Zhang X, Yao X, Qin C, Luo P, Zhang J. Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling. Exp Ther Med 2016;12:925-32. [PMID: 27446297 DOI: 10.3892/etm.2016.3376] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
288 den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47:1211-1218. [PMID: 21239166 DOI: 10.1016/j.ejca.2010.12.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
289 Rabiau N, Dantal Y, Guy L, Ngollo M, Dagdemir A, Kemeny JL, Terris B, Vieillefond A, Boiteux JP, Bignon YJ, Bernard-Gallon D. Gene panel model predictive of outcome in patients with prostate cancer. OMICS 2013;17:407-13. [PMID: 23758475 DOI: 10.1089/omi.2012.0124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
290 Brown PJ, Hyland R, Quyn AJ, West NP, Sebag-Montefiore D, Jayne D, Sagar P, Tolan DJ. Current concepts in imaging for local staging of advanced rectal cancer. Clin Radiol 2019;74:623-36. [PMID: 31036310 DOI: 10.1016/j.crad.2019.03.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
291 Yu DZ, Yu YN, Tian ZB, Zhao QX, Kong XJ, Zhang CP, Wei LZ. Expression of trefoil factor family-3 and β-catenin in different types of colorectal mucosal lesions. Shijie Huaren Xiaohua Zazhi 2011; 19(15): 1579-1584 [DOI: 10.11569/wcjd.v19.i15.1579] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Paul I, Jones JM. Apoptosis block as a barrier to effective therapy in non small cell lung cancer. World J Clin Oncol 2014; 5(4): 588-594 [PMID: 25302163 DOI: 10.5306/wjco.v5.i4.588] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
293 Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V, Parker C, Bellmunt J, Berthold D, Bill-axelson A, Carlsson S, Daugaard G, De Meerleer G, de Reijke T, Dearnaley D, Fizazi K, Fonteyne V, Gillessen S, Heinrich D, Horwich A, Hugosson J, Kataja V, Kwiatkowski M, Nilsson S, Padhani A, Papandreou C, Parker C, Roobol M, Sella A, Valdagni R, Van der Kwast T, Verhagen P, Wiegel T. Prostate cancer: ESMO Consensus Conference Guidelines 2012. Annals of Oncology 2013;24:1141-62. [DOI: 10.1093/annonc/mds624] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
294 Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 2013;10:396-404. [DOI: 10.1038/nrurol.2013.113] [Cited by in Crossref: 139] [Cited by in F6Publishing: 138] [Article Influence: 15.4] [Reference Citation Analysis]
295 del Canto M, García-Martínez L, Fernández-Villa T, Molina AJ, Campanario F, García-Sanz M, López-Abente G, Honrado E, Martín-Sánchez V. Municipal distribution and trends in bladder cancer incidence in health area of León, Spain (1996-2010). Actas Urol Esp 2015;39:349-53. [PMID: 25682356 DOI: 10.1016/j.acuro.2014.09.007] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
296 Sawicki S, Kobierski J, Łapińska-Szumczyk S, Lass P, Cytawa W, Bianek-Bodzak A, Wydra D. Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer. Nucl Med Commun 2013;34:590-6. [PMID: 23542912 DOI: 10.1097/MNM.0b013e328360d8cc] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
297 Lei F, Chen PH, Chen JY, Wang WC, Lin LM, Huang HC, Ho KY, Chen CH, Chen YK. Retrospective study of biopsied head and neck lesions in a cohort of referral Taiwanese patients. Head Face Med 2014;10:28. [PMID: 25047214 DOI: 10.1186/1746-160X-10-28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
298 Skally M, Hanly P, Sharp L. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Health Econ Health Policy. 2013;11:181-192. [PMID: 23549792 DOI: 10.1007/s40258-013-0010-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
299 Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol. 2012;30:4409-4415. [PMID: 23091106 DOI: 10.1200/JCO.2012.43.2278] [Cited by in Crossref: 182] [Cited by in F6Publishing: 78] [Article Influence: 18.2] [Reference Citation Analysis]
300 Al-ebraheem A, Geraki K, Leek R, Harris AL, Farquharson MJ. The use of bio-metal concentrations correlated with clinical prognostic factors to assess human breast tissues: Bio-metal maps in breast cancer correlated with clinical markers. X-Ray Spectrom 2013;42:330-6. [DOI: 10.1002/xrs.2463] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
301 Ćujić D, Stefanoska I, Golubović S. Serum Ferritin in Healthy Women and Breast Cancer Patients. Journal of Medical Biochemistry 2011;30:33-7. [DOI: 10.2478/v10011-010-0027-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
302 Gazouli M, Lyberopoulou A, Pericleous P, Rizos S, Aravantinos G, Nikiteas N, Anagnou NP, Efstathopoulos EP. Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol 2012; 18(32): 4419-4426 [PMID: 22969208 DOI: 10.3748/wjg.v18.i32.4419] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
303 Baszuk P, Janasik B, Pietrzak S, Marciniak W, Reszka E, Białkowska K, Jabłońska E, Muszyńska M, Lesicka M, Derkacz R, Grodzki T, Wójcik J, Wojtyś M, Dębniak T, Cybulski C, Gronwald J, Kubisa B, Wójcik N, Pieróg J, Gajić D, Waloszczyk P, Scott RJ, Wąsowicz W, Jakubowska A, Lubiński J, Lener MR. Lung Cancer Occurrence-Correlation with Serum Chromium Levels and Genotypes. Biol Trace Elem Res 2021;199:1228-36. [PMID: 32648197 DOI: 10.1007/s12011-020-02240-6] [Reference Citation Analysis]
304 Arabsalmani M, Mohammadian-Hafshejani A, Ghoncheh M, Hadadian F, Towhidi F, Vafaee K, Salehiniya H. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J Nephropathol 2017;6:30-42. [PMID: 28042551 DOI: 10.15171/jnp.2017.06] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
305 Zeidan B, Jackson TR, Larkin SE, Cutress RI, Coulton GR, Ashton-Key M, Murray N, Packham G, Gorgoulis V, Garbis SD, Townsend PA. Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target. Oncotarget 2015;6:21421-7. [PMID: 26093083 DOI: 10.18632/oncotarget.4070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
306 Williamson SC, Hartley AE, Heer R. A review of tasquinimod in the treatment of advanced prostate cancer. Drug Des Devel Ther 2013;7:167-74. [PMID: 23662046 DOI: 10.2147/DDDT.S31500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
307 Konings IC, Sidharta GN, Harinck F, Aalfs CM, Poley JW, Kieffer JM, Kuenen MA, Smets EM, Wagner A, van Hooft JE. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology. 2016;25:971-978. [PMID: 26632416 DOI: 10.1002/pon.4047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
308 Broom RJ, Hinder V, Sharples K, Proctor J, Duffey S, Pollard S, Fong PC, Forgeson G, Harris DL, Jameson MB, O'Donnell A, North RT, Deva S, Hanning FJ, Grey A, Findlay MP. Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. Clin Genitourin Cancer 2015;13:50-8. [PMID: 25163397 DOI: 10.1016/j.clgc.2014.07.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
309 Frampas E, Morla O, Regenet N, Eugène T, Dupas B, Meurette G. A solid pancreatic mass: tumour or inflammation? Diagn Interv Imaging 2013;94:741-55. [PMID: 23751230 DOI: 10.1016/j.diii.2013.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
310 Biernacka-Wawrzonek D, Stępka M, Tomaszewska A, Ehrmann-Jóśko A, Chojnowska N, Zemlak M, Muszyński J. Melanosis coli in patients with colon cancer. Prz Gastroenterol 2017;12:22-7. [PMID: 28337232 DOI: 10.5114/pg.2016.64844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
311 Wang H, Zhuo Y, Hu X, Shen W, Zhang Y, Chu T. CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis. Biochemical and Biophysical Research Communications 2015;458:268-73. [DOI: 10.1016/j.bbrc.2015.01.097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
312 Hsiao YC, Chueh FS, Ma YS, Lien JC, Hsia TC, Huang WW, Chou YC, Chen PY, Chung JG, Chen HY, Liu KC. Genistein enhances the effects of L-asparaginase on inducing cell apoptosis in human leukemia cancer HL-60 cells. Environ Toxicol 2021;36:764-72. [PMID: 33347704 DOI: 10.1002/tox.23078] [Reference Citation Analysis]
313 Simo R, Bradley P, Chevalier D, Dikkers F, Eckel H, Matar N, Peretti G, Piazza C, Remacle M, Quer M. European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol 2014;271:2469-79. [PMID: 24609733 DOI: 10.1007/s00405-014-2966-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
314 Visakorpi T. Novel endocrine aspects of prostate cancer. Molecular and Cellular Endocrinology 2012;360:1-2. [DOI: 10.1016/j.mce.2012.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
315 Ausweger C, Burgschwaiger E, Kugler A, Schmidbauer R, Steinek I, Todorov Y, Thurnher D, Krapfenbauer K. Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicine. EPMA J. 2010;1:627-631. [PMID: 23199117 DOI: 10.1007/s13167-010-0054-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
316 Riva A, BØrgesen M, Guldmann-Christensen M, Hauge Kyneb M, Voogd K, Andersen C, Epistolio S, Merlo E, Yding Wolff T, Hamilton-Dutoit S, Lorenzen J, Christensen UB, Frattini M. SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations. PLoS One 2017;12:e0178027. [PMID: 28636636 DOI: 10.1371/journal.pone.0178027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
317 Anandan M, Gurumallesh Prabu H. Dodonaea viscosa Leaf Extract Assisted Synthesis of Gold Nanoparticles: Characterization and Cytotoxicity Against A549 NSCLC Cancer Cells. J Inorg Organomet Polym 2018;28:932-41. [DOI: 10.1007/s10904-018-0799-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
318 Vicens GR, Zafra MS, Moreno-Crespi J, Ferrer BC, Marcos-Gragera R. Incidence variation of prostate and cervical cancer according to socioeconomic level in the Girona Health Region. BMC Public Health 2014;14:1079. [PMID: 25325921 DOI: 10.1186/1471-2458-14-1079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
319 Thakur C, Lu Y, Sun J, Yu M, Chen B, Chen F. Increased expression of mdig predicts poorer survival of the breast cancer patients. Gene 2014;535:218-24. [PMID: 24309373 DOI: 10.1016/j.gene.2013.11.031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
320 Shore ND, Morrow MP, McMullan T, Kraynyak KA, Sylvester A, Bhatt K, Cheung J, Boyer JD, Liu L, Sacchetta B, Rosencranz S, Heath EI, Nordquist L, Cheng HH, Tagawa ST, Appleman LJ, Tutrone R, Garcia JA, Whang YE, Kelly WK, Weiner DB, Bagarazzi ML, Skolnik JM. CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens. Mol Ther 2020;28:1238-50. [PMID: 32208168 DOI: 10.1016/j.ymthe.2020.02.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
321 Ha R, Chow D, Wynn R. Global Trend in Breast Cancer Imaging Research 1992–2012: Bibliometric Study. American Journal of Roentgenology 2014;202:696-7. [DOI: 10.2214/ajr.13.11993] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
322 Puglisi M, Thavasu P, Stewart A, de Bono JS, O'Brien ME, Popat S, Bhosle J, Banerji U. AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines. Lung Cancer 2014;85:141-6. [PMID: 24957682 DOI: 10.1016/j.lungcan.2014.05.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
323 Otto S, van Leeuwen P, Hoekstra J, Merckelbach J, Blom J, Schröder F, Roobol M, de Koning H. Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial? European Journal of Cancer 2010;46:3061-7. [DOI: 10.1016/j.ejca.2010.09.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
324 Cordoba A, Nickers P, Tresch E, Castelain B, Leblanc E, Narducci F, Le Tinier F, Lesoin A, Lacornerie T, Lartigau E. Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report. Rep Pract Oncol Radiother 2015;20:385-92. [PMID: 26549997 DOI: 10.1016/j.rpor.2015.06.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
325 Khan G, Philip PS, Al Ashari M, Houcinat Y, Daoud S. Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells. Exp Mol Pathol 2011;91:466-70. [PMID: 21600202 DOI: 10.1016/j.yexmp.2011.04.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
326 Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B. Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium. Oncotarget 2017;8:106415-28. [PMID: 29290959 DOI: 10.18632/oncotarget.22468] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
327 Moradi M, Mahdavi SS, Nir G, Mohareri O, Koupparis A, Gagnon LO, Fazli L, Casey RG, Ischia J, Jones EC, Goldenberg SL, Salcudean SE. Multiparametric 3D in vivo ultrasound vibroelastography imaging of prostate cancer: Preliminary results. Med Phys 2014;41:073505. [PMID: 24989419 DOI: 10.1118/1.4884226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
328 Crocetti E, Buzzoni C, Quaglia A, Lillini R, Vercelli M. Ageing and other factors behind recent cancer incidence and mortality trends in Italy. Journal of Geriatric Oncology 2012;3:111-9. [DOI: 10.1016/j.jgo.2012.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
329 Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E. Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. World J Urol 2011;29:807-13. [PMID: 21153827 DOI: 10.1007/s00345-010-0627-2] [Cited by in F6Publishing: 65] [Reference Citation Analysis]
330 Fontenete S, Nogueira A, Pina F, Lobo F, Fraga A, Calais da Silva F, Medeiros R. Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer. Genet Test Mol Biomarkers 2012;16:418-22. [PMID: 22288776 DOI: 10.1089/gtmb.2011.0160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
331 Mountzios G, Gkiozos I, Stratakos G, Pissakas G, Charpidou A, Toukfetzian L, Vamvakaris I, Syrigos K. Lung Cancer in Greece. J Thorac Oncol 2021;16:1058-66. [PMID: 34154790 DOI: 10.1016/j.jtho.2020.11.024] [Reference Citation Analysis]
332 Wan Y, Zeng ZC, Xi M, Wan S, Hua W, Liu YL, Zhou YL, Luo HW, Jiang FN, Zhong WD. Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer. Hum Pathol 2015;46:295-303. [PMID: 25532941 DOI: 10.1016/j.humpath.2014.10.027] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
333 Saad El Din K, Loree JM, Sayre EC, Gill S, Brown CJ, Dau H, De Vera MA. Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review. BMC Cancer 2020;20:288. [PMID: 32252672 DOI: 10.1186/s12885-020-06766-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
334 Paraponaris A, Teyssier LS, Ventelou B. Job tenure and self-reported workplace discrimination for cancer survivors 2 years after diagnosis: does employment legislation matter? Health Policy 2010;98:144-55. [PMID: 20619922 DOI: 10.1016/j.healthpol.2010.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
335 Pavlidou A, Dalamaga M, Kroupis C, Konstantoudakis G, Belimezi M, Athanasas G, Dimas K. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J Gastroenterol 2011; 17(12): 1614-1621 [PMID: 21472129 DOI: 10.3748/wjg.v17.i12.1614] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
336 Peltier A, Aoun F, Ameye F, Andrianne R, De Meerleer G, Denis L, Joniau S, Lambrecht A, Billiet I, Vanderdonck F, Roumeguère T, Van Velthoven R. Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists’ Interactions with their Prostate Cancer Patients? Adv Ther 2015;32:863-73. [DOI: 10.1007/s12325-015-0248-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
337 Bosviel R, Dumollard E, Déchelotte P, Bignon YJ, Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012;16:235-244. [PMID: 22339411 DOI: 10.1089/omi.2011.0105] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
338 Tong G, Xu W, Zhang G, Liu J, Zheng Z, Chen Y, Niu P, Xu X. The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study. Cancer Med. 2018;7:5327-5338. [PMID: 30302946 DOI: 10.1002/cam4.1814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
339 Soleyman-Jahi S, Nedjat S, Abdirad A, Hoorshad N, Heidari R, Zendehdel K. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PLoS One. 2014;10:e0122316. [PMID: 25919283 DOI: 10.1371/journal.pone.0122316] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
340 Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int 2016;117:576-83. [PMID: 26332304 DOI: 10.1111/bju.13310] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
341 Watkins DJ, Starling N, Cunningham D, Thomas J, Webb J, Brown G, Barbachano Y, Oates J, Chau I. The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study. Eur J Cancer. 2014;50:1422-1429. [PMID: 24613126 DOI: 10.1016/j.ejca.2014.02.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
342 Usó M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. miRNA detection methods and clinical implications in lung cancer. Future Oncol. 2014;10:2279-2292. [PMID: 25471039 DOI: 10.2217/fon.14.93] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
343 Lunardi S, Jamieson NB, Lim SY, Griffiths KL, Carvalho-Gaspar M, Al-Assar O, Yameen S, Carter RC, McKay CJ, Spoletini G, D'Ugo S, Silva MA, Sansom OJ, Janssen KP, Muschel RJ, Brunner TB. IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget 2014;5:11064-80. [PMID: 25415223 DOI: 10.18632/oncotarget.2519] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
344 Altavilla A, Iacovelli R, Procopio G, Cortesi E. Post-docetaxel therapy in castration resistant prostate cancer - the forest is growing in the desert. Ther Adv Urol 2012;4:107-11. [PMID: 22654962 DOI: 10.1177/1756287212440302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
345 Bravi F, Bosetti C, Filomeno M, Levi F, Garavello W, Galimberti S, Negri E, La Vecchia C. Foods, nutrients and the risk of oral and pharyngeal cancer. Br J Cancer. 2013;109:2904-2910. [PMID: 24149181 DOI: 10.1038/bjc.2013.667] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
346 Frank M, Mittendorf T. Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review. Pharmacoeconomics 2013;31:215-28. [PMID: 23338963 DOI: 10.1007/s40273-012-0017-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
347 Jurcevic S, Olsson B, Klinga-Levan K. MicroRNA expression in human endometrial adenocarcinoma. Cancer Cell Int 2014;14:88. [PMID: 25419182 DOI: 10.1186/s12935-014-0088-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
348 Moll J, Kelly TN, Byrne D, Sarafianou M, Krozer V, Craddock IJ. Microwave radar imaging of heterogeneous breast tissue integrating a priori information. Int J Biomed Imaging 2014;2014:943549. [PMID: 25435861 DOI: 10.1155/2014/943549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
349 Jégu J, Binder-Foucard F, Borel C, Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 2013;49:9-14. [PMID: 22840787 DOI: 10.1016/j.oraloncology.2012.06.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
350 Gartrell BA, Coleman RE, Fizazi K, Miller K, Saad F, Sternberg CN, Galsky MD. Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer. Eur Urol 2014;65:278-86. [PMID: 23706567 DOI: 10.1016/j.eururo.2013.05.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
351 Noguchi M, Moriya F, Suekane S, Matsuoka K, Arai G, Matsueda S, Sasada T, Yamada A, Itoh K. Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy. Prostate 2012;72:834-45. [DOI: 10.1002/pros.21485] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
352 Marberger M, Barentsz J, Emberton M, Hugosson J, Loeb S, Klotz L, Koch M, Shariat SF, Vickers A. Novel approaches to improve prostate cancer diagnosis and management in early-stage disease: PROSTATE CANCER DIAGNOSIS AND MANAGEMENT IN EARLY-STAGE DISEASE. BJU International 2012;109:1-7. [DOI: 10.1111/j.1464-410x.2011.10870.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
353 Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. J Clin Pathol 2015;68:795-801. [DOI: 10.1136/jclinpath-2015-202987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
354 Chen CH, Lin CL, Kao CH. Association between gallbladder stone disease and prostate cancer: A nationwide population-based study. Oncotarget 2016;7:64380-9. [PMID: 27147576 DOI: 10.18632/oncotarget.9062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
355 Botelho F, Pina F, Figueiredo L, Cruz F, Lunet N. Does baseline total testosterone improve the yielding of prostate cancer screening? European Journal of Cancer 2012;48:1657-63. [DOI: 10.1016/j.ejca.2012.01.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
356 Torfs S, Cadron I, Amant F, Leunen K, Berteloot P, Vergote I. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. European Journal of Cancer 2012;48:1332-40. [DOI: 10.1016/j.ejca.2012.01.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
357 Melmer A, Fineder L, Lamina C, Kollerits B, Dieplinger B, Braicu I, Sehouli J, Cadron I, Vergote I, Mahner S, Zeimet AG, Castillo-Tong DC, Ebenbichler CF, Zeillinger R, Dieplinger H. Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium. Gynecol Oncol 2013;128:38-43. [PMID: 23063758 DOI: 10.1016/j.ygyno.2012.09.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
358 Wang Y, Zhang H, Shen W, He P, Zhou Z. Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials. J Cancer Res Clin Oncol 2018;144:1751-68. [PMID: 29797220 DOI: 10.1007/s00432-018-2664-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
359 Roshani R, McCarthy F, Hagemann T. Inflammatory cytokines in human pancreatic cancer. Cancer Lett. 2014;345:157-163. [PMID: 23879960 DOI: 10.1016/j.canlet.2013.07.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
360 Dai L, Wang W, Zhang S, Jiang Q, Wang R, Dai L, Cheng L, Yang Y, Wei YQ, Deng HX. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo. Cell Biol Int. 2012;36:765-770. [PMID: 22574716 DOI: 10.1042/cbi20110404] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
361 Rak B, Mehlich D, Garbicz F, Domosud Z, Paskal W, Marczewska JM, Włodarski PK. Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer. Cancer Genomics Proteomics 2017;14:389-401. [PMID: 28871006 DOI: 10.21873/cgp.20049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
362 Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB. Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants. Nutrients 2019;11:E336. [PMID: 30720759 DOI: 10.3390/nu11020336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
363 Holleczek B, Jansen L, Brenner H. Breast cancer survival in Germany: a population-based high resolution study from Saarland. PLoS One 2013;8:e70680. [PMID: 23936237 DOI: 10.1371/journal.pone.0070680] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
364 Caffo O, Veccia A, Fellin G, Mussari S, Russo L, Tomio L, Galligioni E. Frequency of brain metastases from prostate cancer: an 18-year single-institution experience. J Neurooncol. 2013;111:163-167. [PMID: 23096134 DOI: 10.1007/s11060-012-0994-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
365 Rohrmann S, Grote VA, Becker S, Rinaldi S, Tjønneland A, Roswall N, Grønbæk H, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Boeing H, Drogan D, Dilis V, Lagiou P, Trichopoulou A, Palli D, Tagliabue G, Tumino R, Vineis P, Mattiello A, Rodríguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink S, Peeters PH, Lindkvist B, Johansen D, Sund M, Ye W, Khaw KT, Wareham NJ, Allen NE, Crowe FL, Fedirko V, Jenab M, Michaud DS, Norat T, Riboli E, Bueno-de-Mesquita HB, Kaaks R. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2012;106:1004-10. [PMID: 22315049 DOI: 10.1038/bjc.2012.19] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
366 Keyzer-dekker CM, Van Esch L, Schreurs WH, van Berlo CL, Roukema JA, De Vries J, van der Steeg AF. Health care utilization one year following the diagnosis benign breast disease or breast cancer. The Breast 2012;21:746-50. [DOI: 10.1016/j.breast.2012.01.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
367 Moghbeli M, Moghbeli F, Forghanifard MM, Abbaszadegan MR. Cancer stem cell detection and isolation. Med Oncol. 2014;31:69. [PMID: 25064729 DOI: 10.1007/s12032-014-0069-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
368 Gadaleta RM, Scialpi N, Peres C, Cariello M, Ko B, Luo J, Porru E, Roda A, Sabbà C, Moschetta A. Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis. Sci Rep 2018;8:17210. [PMID: 30464200 DOI: 10.1038/s41598-018-35496-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
369 Pinto F, Totaro A, Calarco A, Sacco E, Volpe A, Racioppi M, D’addessi A, Gulino G, Bassi P. Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. Urol Int 2011;86:373-82. [DOI: 10.1159/000324515] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
370 Kawamoto Y, Komatsu Y, Yuki S, Sawada K, Muranaka T, Harada K, Nakatsumi H, Fukushima H, Ishiguro A, Dazai M, Hatanaka K, Nakamura M, Iwanaga I, Uebayashi M, Sogabe S, Kobayashi Y, Miyagishima T, Ono K, Sakamoto N, Sakata Y. Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer. BMC Cancer 2017;17:837. [PMID: 29221445 DOI: 10.1186/s12885-017-3850-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
371 Stamatakis K, Jimenez-Martinez M, Jimenez-Segovia A, Chico-Calero I, Conde E, Galán-Martínez J, Ruiz J, Pascual A, Barrocal B, López-Pérez R, García-Bermejo ML, Fresno M. Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression. Oncotarget 2015;6:39941-59. [PMID: 26498686 DOI: 10.18632/oncotarget.5402] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
372 Lecouvet FE, Simon M, Tombal B, Jamart J, Vande Berg BC, Simoni P. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa). Eur Radiol 2010;20:2973-82. [DOI: 10.1007/s00330-010-1879-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
373 Riboe DG, Dogan TS, Brodersen J. Potential biases in colorectal cancer screening using faecal occult blood test. J Eval Clin Pract 2013;19:311-6. [PMID: 22332801 DOI: 10.1111/j.1365-2753.2012.01824.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
374 Andrighetto LV, Poziomyck AK. SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE. Arq Bras Cir Dig 2016;29:276-8. [PMID: 28076486 DOI: 10.1590/0102-6720201600040015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
375 Denis CJ, Van Acker N, De Schepper S, De Bie M, Andries L, Fransen E, Hendriks D, Kockx MM, Lambeir AM. Mapping of carboxypeptidase m in normal human kidney and renal cell carcinoma: expression in tumor-associated neovasculature and macrophages. J Histochem Cytochem 2013;61:218-35. [PMID: 23172796 DOI: 10.1369/0022155412470456] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
376 Hawkes AL, Lynch BM, Owen N, Aitken JF. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer 2011;47:267-76. [PMID: 21074408 DOI: 10.1016/j.ejca.2010.10.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
377 Radespiel-tröger M, Meyer M, Fenner M. Geographic differences and time trends of intraoral cancer incidence and mortality in Bavaria, Germany. Journal of Cranio-Maxillofacial Surgery 2012;40:e285-92. [DOI: 10.1016/j.jcms.2012.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
378 Yokota M, Kojima M, Higuchi Y, Nishizawa Y, Kobayashi A, Ito M, Saito N, Ochiai A. Spread of tumor microenvironment contributes to colonic obstruction through subperitoneal fibroblast activation in colon cancer. Cancer Sci 2015;106:466-74. [PMID: 25613547 DOI: 10.1111/cas.12615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
379 Hsiao Y, Lin S, Chien K, Chen S, Wu C, Chang Y, Chi L, Chu LJ, Chiang W, Chien C, Chang K, Chang Y, Yu J. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Analytica Chimica Acta 2020;1100:118-30. [DOI: 10.1016/j.aca.2019.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
380 Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer 2012;12:369. [PMID: 22920721 DOI: 10.1186/1471-2407-12-369] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
381 Ferrís-i-Tortajada J, García-i-Castell J, Berbel-Tornero O, Ortega-García JA. [Constitutional risk factors in prostate cancer]. Actas Urol Esp 2011;35:282-8. [PMID: 21435741 DOI: 10.1016/j.acuro.2010.12.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
382 Kirner A, Mayer-Mokler A, Reinhardt C. IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer. Hum Vaccin Immunother 2014;10:3179-89. [PMID: 25625928 DOI: 10.4161/21645515.2014.983857] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
383 Feng H, Wang Y, Su J, Liang H, Zhang C, Chen X, Yao W. MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. Pancreas 2016;45:1263-71. [DOI: 10.1097/mpa.0000000000000677] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
384 Frei R, Staedler D, Raja A, Franke R, Sasse F, Gerber-lemaire S, Waser J. Total Synthesis and Biological Evaluation of Jerantinine E. Angew Chem Int Ed 2013;52:13373-6. [DOI: 10.1002/anie.201305533] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
385 Eshuis WJ, van Eijck CH, Gerhards MF, Coene PP, de Hingh IH, Karsten TM, Bonsing BA, Gerritsen JJ, Bosscha K, Spillenaar Bilgen EJ. Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreatoduodenectomy: a randomized controlled trial. Ann Surg. 2014;259:45-51. [PMID: 24096769 DOI: 10.1097/sla.0b013e3182a6f529] [Cited by in Crossref: 64] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
386 Adjakly M, Bosviel R, Rabiau N, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon D. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 2011;3:795-803. [PMID: 22126297 DOI: 10.2217/epi.11.103] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
387 Li Q, Wang Q, Xu X, Ren S, Wang L. Association between IL-4 -589C>T polymorphism and colorectal cancer risk. Tumour Biol 2014;35:2675-9. [PMID: 24218339 DOI: 10.1007/s13277-013-1352-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
388 Vallen MJ, Massuger LF, ten Dam GB, Bulten J, van Kuppevelt TH. Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue. Gynecol Oncol 2012;127:202-9. [PMID: 22733095 DOI: 10.1016/j.ygyno.2012.06.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
389 Morales-barrera R, Bellmunt J, Suárez C, Valverde C, Guix M, Serrano C, Gallén M, Carles J. Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function. European Journal of Cancer 2012;48:1816-21. [DOI: 10.1016/j.ejca.2012.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
390 Li C, Wu ZH, Yuan K. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Dis Markers 2020;2020:8899337. [PMID: 33133307 DOI: 10.1155/2020/8899337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
391 Herszényi L, Hritz I, Lakatos G, Varga MZ, Tulassay Z. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci. 2012;13:13240-13263. [PMID: 23202950 DOI: 10.3390/ijms131013240] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 8.2] [Reference Citation Analysis]
392 Fakhoury HM, Noureddine S, Tamim H, Chmaisse H, Makki R. Association of MMP3 -1171(5A>6A) Polymorphism with Lung Cancer in Lebanon. Genetic Testing and Molecular Biomarkers 2012;16:988-90. [DOI: 10.1089/gtmb.2012.0042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
393 Pita-Fernández S, González-Sáez L, López-Calviño B, Seoane-Pillado T, Rodríguez-Camacho E, Pazos-Sierra A, González-Santamaría P, Pértega-Díaz S. Effect of diagnostic delay on survival in patients with colorectal cancer: a retrospective cohort study. BMC Cancer 2016;16:664. [PMID: 27549406 DOI: 10.1186/s12885-016-2717-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
394 Slagelse C, Petersen KL, Dahl JB, Finnerup K, Greene K, Leong SP, Levine J, Rowbotham M, Werner MU, Finnerup NB. Persistent postoperative pain and sensory changes following lymph node excision in melanoma patients: a topical review. Melanoma Res 2014;24:93-8. [PMID: 24346167 DOI: 10.1097/CMR.0000000000000041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
395 Hessels D, Schalken JA. Urinary biomarkers for prostate cancer: a review. Asian J Androl 2013;15:333-9. [PMID: 23524531 DOI: 10.1038/aja.2013.6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
396 Muir VJ, Dhillon S. Erlotinib: As Maintenance Monotherapy in Non-Small-Cell Lung Cancer. BioDrugs 2011;25:139-46. [DOI: 10.2165/11206910-000000000-00000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
397 Patsea E, Kaklamanis L, Batistatou A; Hellenic Society of Pathology. The first report of a 5-year period cancer registry in Greece (2009-2013): a pathology-based cancer registry. Virchows Arch 2018;472:677-82. [PMID: 29302754 DOI: 10.1007/s00428-017-2287-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
398 Guo Z, Liu D, Su Z. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway. Tumour Biol 2015;36:4777-83. [PMID: 25636449 DOI: 10.1007/s13277-015-3129-4] [Reference Citation Analysis]
399 van Jaarsveld MTM, Helleman J, Boersma AWM, van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RHJ, Berns EMJJ, Verweij J, Pothof J, Wiemer EAC. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 2013;32:4284-93. [DOI: 10.1038/onc.2012.433] [Cited by in Crossref: 137] [Cited by in F6Publishing: 141] [Article Influence: 13.7] [Reference Citation Analysis]
400 Velazquez ER, Aerts HJ, Oberije C, De Ruysscher D, Lambin P. Prediction of residual metabolic activity after treatment in NSCLC patients. Acta Oncol 2010;49:1033-9. [PMID: 20831492 DOI: 10.3109/0284186X.2010.498441] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
401 Curran MP. Lapatinib: In Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer. Drugs 2010;70:1411-22. [DOI: 10.2165/11204550-000000000-00000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
402 Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer. 2010;46:2593-2604. [PMID: 20843488 DOI: 10.1016/j.ejca.2010.07.028] [Cited by in Crossref: 287] [Cited by in F6Publishing: 219] [Article Influence: 26.1] [Reference Citation Analysis]
403 Bangma CH, Bul M, Roobol M. The Prostate cancer Research International: Active Surveillance study. Current Opinion in Urology 2012;22:216-21. [DOI: 10.1097/mou.0b013e328351dcc7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
404 Manchon-Walsh P, Borras JM, Espinas JA, Aliste L; Catalonian Rectal Cancer Group. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol 2011;37:325-33. [PMID: 21296543 DOI: 10.1016/j.ejso.2011.01.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
405 Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, Briganti A, Montorsi F, Rigatti P, Zangrillo A. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011;343:d5701. [PMID: 22012809 DOI: 10.1136/bmj.d5701] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
406 Roelants M, Huygens A, Crnolatac I, Van Cleynenbreugel B, Lerut E, Van Poppel H, de Witte PA. Evans blue as a selective dye marker for white-light diagnosis of non-muscle-invasive bladder cancer: an in vitro study. BJU Int 2012;109:300-5. [PMID: 21854534 DOI: 10.1111/j.1464-410X.2011.10465.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
407 Tamaru Y, Oka S, Tanaka S, Nagata S, Hiraga Y, Kuwai T, Furudoi A, Tamura T, Kunihiro M, Okanobu H, Nakadoi K, Kanao H, Higashiyama M, Arihiro K, Kuraoka K, Shimamoto F, Chayama K. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol 2017;52:1169-79. [PMID: 28194526 DOI: 10.1007/s00535-017-1318-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
408 Dieperink K, Wagner L, Hansen S, Hansen O. Embracing life after prostate cancer. A male perspective on treatment and rehabilitation: Rehabilitation in prostate cancer care. Eur J Cancer Care (Engl) 2013;22:549-58. [DOI: 10.1111/ecc.12061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
409 Carton M, Barul C, Menvielle G, Cyr D, Sanchez M, Pilorget C, Trétarre B, Stücker I, Luce D; ICARE Study Group. Occupational exposure to solvents and risk of head and neck cancer in women: a population-based case-control study in France. BMJ Open 2017;7:e012833. [PMID: 28069619 DOI: 10.1136/bmjopen-2016-012833] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
410 Lindberg A, Talala K, Kujala P, Stenman UH, Taari K, Kilpeläinen TP, Tammela TL, Auvinen A. Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer. Int J Cancer 2019;145:632-8. [PMID: 30653262 DOI: 10.1002/ijc.32129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Frattini M, Molinari F, Epistolio S. The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies. J Thorac Dis 2017;9:4240-3. [PMID: 29268482 DOI: 10.21037/jtd.2017.10.38] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
412 de Martino M, Shariat SF, Hofbauer SL, Lucca I, Taus C, Wiener HG, Haitel A, Susani M, Klatte T. Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer. World J Urol 2015;33:105-10. [DOI: 10.1007/s00345-014-1267-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
413 Keck B, Ott OJ, Häberle L, Kunath F, Weiss C, Rödel C, Sauer R, Fietkau R, Wullich B, Krause FS. Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J Urol 2013;31:1023-8. [DOI: 10.1007/s00345-012-0971-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
414 Gerola S, Nittka S, Kähler G, Tao S, Brenner H, Binelli G, Eils R, Brors B, Neumaier M. Genetic variants in apoptosis-related genes associated with colorectal hyperplasia: SNPs Associated with Colorectal Hyperplasia. Genes Chromosomes Cancer 2014;53:769-78. [DOI: 10.1002/gcc.22185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
415 Olariu CI, Yiu HHP, Bouffier L, Nedjadi T, Costello E, Williams SR, Halloran CM, Rosseinsky MJ. Multifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancer. J Mater Chem 2011;21:12650. [DOI: 10.1039/c1jm11370d] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
416 Jeurnink SM, Ros MM, Leenders M, van Duijnhoven FJ, Siersema PD, Jansen EH, van Gils CH, Bakker MF, Overvad K, Roswall N, Tjønneland A, Boutron-Ruault MC, Racine A, Cadeau C, Grote V, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Benetou V, Valanou E, Palli D, Krogh V, Vineis P, Tumino R, Mattiello A, Weiderpass E, Skeie G, Castaño JM, Duell EJ, Barricarte A, Molina-Montes E, Argüelles M, Dorronsoro M, Johansen D, Lindkvist B, Sund M, Crowe FL, Khaw KT, Jenab M, Fedirko V, Riboli E, Bueno-de-Mesquita HB. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition: a nested case-control study: plasma micronutrients and pancreatic cancer risk. Int J Cancer 2015;136:E665-76. [PMID: 25175624 DOI: 10.1002/ijc.29175] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
417 Sardanelli F, Trimboli RM. Preoperative MRI: did randomized trials conclude the debate? Eur J Radiol 2012;81 Suppl 1:S135-6. [PMID: 23083563 DOI: 10.1016/S0720-048X(12)70056-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
418 Vandepitte J, Roelants M, Cleynenbreugel BV, Hettinger K, Lerut E, Van Poppel H, de Witte PAM. Biodistribution and photodynamic effects of polyvinylpyrrolidone-hypericin using multicellular spheroids composed of normal human urothelial and T24 transitional cell carcinoma cells. J Biomed Opt 2011;16:018001. [DOI: 10.1117/1.3533316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
419 Sternberg CN, Hawkins RE, Wagstaff J, Salman P, Mardiak J, Barrios CH, Zarba JJ, Gladkov OA, Lee E, Szczylik C, McCann L, Rubin SD, Chen M, Davis ID. A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. Eur J Cancer. 2013;49:1287-1296. [PMID: 23321547 DOI: 10.1016/j.ejca.2012.12.010] [Cited by in Crossref: 286] [Cited by in F6Publishing: 257] [Article Influence: 31.8] [Reference Citation Analysis]
420 Uzoh CC, Holly JM, Biernacka KM, Persad RA, Bahl A, Gillatt D, Perks CM. Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel. Br J Cancer 2011;104:1587-93. [PMID: 21487405 DOI: 10.1038/bjc.2011.127] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
421 Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, Kopelovich L, Lipkin SM, Gruber SB, Moreno V. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis 2012;27:169-76. [PMID: 22294764 DOI: 10.1093/mutage/ger066] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
422 Ahn SH, Hong HJ, Kwon SY, Kwon KH, Roh JL, Ryu J, Park JH, Baek SK, Lee GH, Lee SY, Lee JC, Chung MK, Joo YH, Ji YB, Hah JH, Kwon M, Park YM, Song CM, Shin SC, Ryu CH, Lee DY, Lee YC, Chang JW, Jeong HM, Cho JK, Cha W, Chun BJ, Choi IJ, Choi HG, Lee KD; Korean Society of Thyroid-Head and Neck Surgery Guideline Task Force. Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol 2017;10:1-43. [PMID: 28043099 DOI: 10.21053/ceo.2016.01389] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
423 Pinkawa M, Piroth MD, Holy R, Escobar-Corral N, Caffaro M, Djukic V, Klotz J, Eble MJ. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis. Strahlenther Onkol. 2012;188:917-925. [PMID: 22933033 DOI: 10.1007/s00066-012-0172-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
424 Grifantini R, Taranta M, Gherardini L, Naldi I, Parri M, Grandi A, Giannetti A, Tombelli S, Lucarini G, Ricotti L, Campagnoli S, De Camilli E, Pelosi G, Baldini F, Menciassi A, Viale G, Pileri P, Cinti C. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer. Journal of Controlled Release 2018;280:76-86. [DOI: 10.1016/j.jconrel.2018.04.052] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
425 Bergmann L, Enzmann H, Broich K, Hebborn A, Marsoni S, Goh L, Smyth J, Zwierzina H. Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? Annals of Oncology 2014;25:303-6. [DOI: 10.1093/annonc/mdt488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
426 Kirby M. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU Int 2013;111:854-6. [PMID: 23615028 DOI: 10.1111/j.1464-410X.2012.11722.x] [Reference Citation Analysis]
427 Yalcin S, Trad D, Kader YA, Halawani H, Demir OG, Mall R, Meshcheryakov A, Nasr F, Nosworthy A, Osinsky D. Personalized treatment is better than one treatment fits all in the management of patients with mCRC: a consensus statement. Future Oncol. 2014;10:2643-2657. [PMID: 25531050 DOI: 10.2217/fon.14.203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
428 Emin L, Meeus P, Beurrier F, Ferraioli D, Carrabin N, Ray-coquard I, Treilleux I, Chopin N. Complications après exentération pelvienne postérieure modifiée selon Hudson dans le cadre de tumeurs malignes ovariennes. Gynécologie Obstétrique & Fertilité 2015;43:342-7. [DOI: 10.1016/j.gyobfe.2015.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
429 Haldrup C, Kosaka N, Ochiya T, Borre M, Høyer S, Orntoft TF, Sorensen KD. Profiling of circulating microRNAs for prostate cancer biomarker discovery. Drug Deliv and Transl Res 2014;4:19-30. [DOI: 10.1007/s13346-013-0169-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
430 Van Calster B, Timmerman D, Valentin L, McIndoe A, Ghaem-Maghami S, Testa AC, Vergote I, Bourne T. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol. BJOG 2012;119:662-71. [PMID: 22390753 DOI: 10.1111/j.1471-0528.2012.03297.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
431 Ho JR, Chapeaublanc E, Kirkwood L, Nicolle R, Benhamou S, Lebret T, Allory Y, Southgate J, Radvanyi F, Goud B. Deregulation of Rab and Rab effector genes in bladder cancer. PLoS One 2012;7:e39469. [PMID: 22724020 DOI: 10.1371/journal.pone.0039469] [Cited by in Crossref: 66] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
432 Oostendorp LJ, Stalmeier PF, Donders AR, van der Graaf WT, Ottevanger PB. Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review. Lancet Oncol 2011;12:1053-61. [PMID: 21621462 DOI: 10.1016/S1470-2045(11)70045-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
433 Genestreti G, Bongiovanni A, Burgio MA, Burgio SL, Musto A, Rossi A, Monti M, Scarpi E, Ulivi P, Bravaccini S, Dubini A, Matteucci F, Gavelli G. 111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance. Nucl Med Commun 2015;36:135-42. [PMID: 25321157 DOI: 10.1097/MNM.0000000000000221] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
434 Riemann JF. Colonoscopy screening: status in Europe. Dig Dis 2011;29 Suppl 1:53-5. [PMID: 22104754 DOI: 10.1159/000331130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
435 Nozawa H, Sunami E, Nakajima J, Nagawa H, Kitayama J. Synchronous and metachronous lung metastases in patients with colorectal cancer: A 20-year monocentric experience. Exp Ther Med. 2012;3:449-456. [PMID: 22969910 DOI: 10.3892/etm.2011.443] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
436 Tomar LR, Agarwal MP, Aggarwal A, Narang S, Mishra K. Scalp swelling: An unusual presentation of small cell lung carcinoma. Indian Dermatol Online J 2015;6:55-7. [PMID: 25657924 DOI: 10.4103/2229-5178.148954] [Reference Citation Analysis]
437 Zhang XF, Huang FH, Zhang GL, Bai DP, Massimo DF, Huang YF, Gurunathan S. Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3). Int J Nanomedicine 2017;12:7551-75. [PMID: 29075115 DOI: 10.2147/IJN.S144161] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 6.2] [Reference Citation Analysis]
438 Yan S, Deng Y, Qiang Y, Xi Q, Liu R, Yang S, Liu J, Tang C, Zhong J, Wang Y. SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation. Tumor Biol 2015;36:4633-42. [DOI: 10.1007/s13277-015-3111-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
439 Xie J, Dong H, Chen H, Zhao R, Sinko PJ, Shen W, Wang J, Lu Y, Yang X, Xie F, Jia L. Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial. J Nanobiotechnology 2015;13:9. [PMID: 25643843 DOI: 10.1186/s12951-015-0072-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
440 Redondo-Sánchez D, Rodríguez-Barranco M, Ameijide A, Alonso FJ, Fernández-Navarro P, Jiménez-Moleón JJ, Sánchez MJ. Cancer incidence estimation from mortality data: a validation study within a population-based cancer registry. Popul Health Metr 2021;19:18. [PMID: 33757540 DOI: 10.1186/s12963-021-00248-1] [Reference Citation Analysis]
441 Lütje S, Boerman OC, van Rij CM, Sedelaar M, Helfrich W, Oyen WJ, Mulders PF. Prospects in radionuclide imaging of prostate cancer. Prostate. 2012;72:1262-1272. [PMID: 22127918 DOI: 10.1002/pros.22462] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
442 Gulbake A, Jain A, Jain A, Jain A, Jain SK. Insight to drug delivery aspects for colorectal cancer. World J Gastroenterol 2016; 22(2): 582-599 [PMID: 26811609 DOI: 10.3748/wjg.v22.i2.582] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
443 Delyon J, Mateus C, Lefeuvre D, Lanoy E, Zitvogel L, Chaput N, Roy S, Eggermont AM, Routier E, Robert C. Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. Ann Oncol 2013;24:1697-703. [PMID: 23439861 DOI: 10.1093/annonc/mdt027] [Cited by in Crossref: 220] [Cited by in F6Publishing: 212] [Article Influence: 24.4] [Reference Citation Analysis]
444 Konings IC, Harinck F, Poley JW, Aalfs CM, van Rens A, Krak NC, Wagner A, Nio CY, Sijmons RH, van Dullemen HM, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ; Dutch Research Group on Pancreatic Cancer Surveillance in High-Risk Individuals. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer. Pancreas 2017;46:28-34. [PMID: 27846136 DOI: 10.1097/MPA.0000000000000725] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
445 Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. The Lancet Oncology 2012;13:e95-e102. [DOI: 10.1016/s1470-2045(11)70323-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
446 de la Cueva A, Ramírez de Molina A, Alvarez-Ayerza N, Ramos MA, Cebrián A, Del Pulgar TG, Lacal JC. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts. PLoS One. 2013;8:e64961. [PMID: 23762272 DOI: 10.1371/journal.pone.0064961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
447 Crombie JL, LaCasce AS. Current considerations in AYA Hodgkin lymphoma. Br J Haematol 2019;184:72-81. [PMID: 30460695 DOI: 10.1111/bjh.15640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
448 Liu F, Wang X, Liu H, Wang Y, Liu X, Hao X, Li H. LncRNA BX357664 inhibits cell proliferation and invasion and promotes cell apoptosis in human colorectal cancer cells. Oncol Lett 2018;15:8237-44. [PMID: 29844809 DOI: 10.3892/ol.2018.8435] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
449 Senkus E, Gomez H, Dirix L, Jerusalem G, Murray E, Van Tienhoven G, Westenberg AH, Bottomley A, Rapion J, Bogaerts J, Di Leo A, Nešković-konstantinović Z. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98: Fertility attitudes in young patients with breast cancer. Psycho-Oncology 2014;23:173-82. [DOI: 10.1002/pon.3384] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
450 Colloca G, Venturino A. The evolving role of familial history for prostate cancer. Acta Oncol 2011;50:14-24. [PMID: 20874046 DOI: 10.3109/0284186X.2010.521191] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
451 Trouilloud I, Dubreuil O, Boussaha T, Lepère C, Landi B, Zaanan A, Bachet JB, Taieb J. Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine. Clin Res Hepatol Gastroenterol 2011;35:364-74. [PMID: 21435966 DOI: 10.1016/j.clinre.2011.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
452 Mathieu R, Evrard B, Fromont G, Rioux-Leclercq N, Godet J, Cathelineau X, Guillé F, Primig M, Chalmel F. Expression screening of cancer/testis genes in prostate cancer identifies NR6A1 as a novel marker of disease progression and aggressiveness. Prostate 2013;73:1103-14. [PMID: 23532770 DOI: 10.1002/pros.22659] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
453 Page AJ, Cosgrove DC, Herman JM, Pawlik TM. Advances in understanding of colorectal liver metastasis and implications for the clinic. Expert Review of Gastroenterology & Hepatology 2014;9:245-59. [DOI: 10.1586/17474124.2014.940897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
454 Shishida M, Toyota K, Ikeda M, Karakuchi N, Inoue M, Saito Y, Takahashi T. Clinical Complete Response after Chemotherapy and Palliative Surgery for Unresectable Gastric Cancer. Case Rep Oncol 2020;13:689-95. [PMID: 32774258 DOI: 10.1159/000507781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
455 Yokota M, Kojima M, Nomura S, Nishizawa Y, Kobayashi A, Ito M, Ochiai A, Saito N. Clinical Impact of Elastic Laminal Invasion in Colon Cancer: Elastic Laminal Invasion-Positive Stage II Colon Cancer Is a High-Risk Equivalent to Stage III. Diseases of the Colon & Rectum 2014;57:830-8. [DOI: 10.1097/dcr.0000000000000124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
456 Greimel E, Kristensen GB, van der Burg ME, Coronado P, Rustin G, del Rio AS, Reed NS, Nordal RR, Coens C, Vergote I; European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group. Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy. Gynecol Oncol 2013;131:437-44. [PMID: 23994107 DOI: 10.1016/j.ygyno.2013.08.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
457 Verleye L, Ottevanger PB, Kristensen GB, Ehlen T, Johnson N, van der Burg ME, Reed NS, Verheijen RH, Gaarenstroom KN, Mosgaard B, Seoane JM, van der Velden J, Lotocki R, van der Graaf W, Penninckx B, Coens C, Stuart G, Vergote I. Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial. Eur J Cancer 2011;47:57-64. [PMID: 20850296 DOI: 10.1016/j.ejca.2010.08.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
458 Yan H, Wang X, Niu J, Wang Y, Wang P, Liu Q. Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells. PLoS One 2014;9:e95609. [PMID: 24752286 DOI: 10.1371/journal.pone.0095609] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
459 Urban P, Rabajdova MB, Varga J, Kruzliak P, Fialkovicova V, Durovcova E, Marekova M. Vascular marker expression during the development of various types of gynaecological malignancy. Tumor Biol 2014;35:11229-35. [DOI: 10.1007/s13277-014-2447-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
460 Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer. 2013;49:938-945. [PMID: 23079475 DOI: 10.1016/j.ejca.2012.09.030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
461 Therasakvichya S, Kuljarusnont S, Petsuksiri J, Chaopotong P, Achariyapota V, Srichaikul P, Jaishuen A. Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences. J Gynecol Oncol 2016;27:e48. [PMID: 27329196 DOI: 10.3802/jgo.2016.27.e48] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
462 Long T, Su J, Tang W, Luo Z, Liu S, Liu Z, Zhou H, Qi M, Zeng W, Zhang J, Chen X. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells. Cancer Lett 2013;339:93-101. [PMID: 23879967 DOI: 10.1016/j.canlet.2013.07.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
463 Zhan T, Hahn F, Hielscher T, Betge J, Kähler G, Ebert MP, Belle S. Frequent co-occurrence of high-grade dysplasia in large flat colonic polyps (>20 mm) and synchronous polyps. BMC Gastroenterol 2015;15:82. [PMID: 26160557 DOI: 10.1186/s12876-015-0312-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
464 Ananias HJK, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH. 99m Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7–14) as a Targeted Imaging Agent with MicroSPECT in a PC-3 Prostate Cancer Xenograft Model. Mol Pharmaceutics 2011;8:1165-73. [DOI: 10.1021/mp200014h] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
465 Yu XM, Liu Y, Jin T, Liu J, Wang J, Ma C, Pan XL. The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas. PLoS One 2013;8:e66975. [PMID: 23805287 DOI: 10.1371/journal.pone.0066975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
466 Chen Y, Xin X, Li J, Xu J, Yu X, Li T, Mo Z, Hu Y. RTK/ERK pathway under natural selection associated with prostate cancer. PLoS One 2013;8:e78254. [PMID: 24223781 DOI: 10.1371/journal.pone.0078254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
467 Bussu F, Graziani C, Gallus R, Cittadini A, Galli J, DE Corso E, DI Cintio G, Corbi M, Almadori G, Boninsegna A, Paludetti G, Sgambato A. IFN-γ and other serum cytokines in head and neck squamous cell carcinomas. Acta Otorhinolaryngol Ital 2018;38:94-102. [PMID: 29967556 DOI: 10.14639/0392-100X-1530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
468 Amkreutz LC, Mertens HJ, Nurseta T, Engelen MJ, Bergmans M, Nolting E, Van Gorp T, Kruitwagen RF. The value of imaging of the lungs in the diagnostic workup of patients with endometrial cancer. Gynecol Oncol 2013;131:147-50. [PMID: 23838035 DOI: 10.1016/j.ygyno.2013.06.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
469 van Bruinessen IR, van Weel-baumgarten EM, Gouw H, Zijlstra JM, Albada A, van Dulmen S. Barriers and facilitators to effective communication experienced by patients with malignant lymphoma at all stages after diagnosis: The influences on effective communication from a patient viewpoint. Psycho-Oncology 2013;22:2807-14. [DOI: 10.1002/pon.3352] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
470 Reimers MS, Zeestraten EC, Kuppen PJ, Liefers GJ, van de Velde CJ. Biomarkers in precision therapy in colorectal cancer. Gastroenterol Rep (Oxf) 2013;1:166-83. [PMID: 24759962 DOI: 10.1093/gastro/got022] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
471 Jalón Monzón A, Escaf Barmadah S, Viña Alonso LM, Jalón Monzón M. [Current aspects of prostate cancer screening]. Semergen 2017;43:387-93. [PMID: 27562331 DOI: 10.1016/j.semerg.2016.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
472 Gómez-ruiz S, Stanojković TP, Kaluđerović GN. Synthesis, characterization, biological studies and in vitro cytotoxicity on human cancer cell lines of titanium(IV) and tin(IV) derivatives with the α,α′-dimercapto-o-xylene ligand: Titanium and tin complexes with α,α′-dimercapto-o-xylene ligand. Appl Organometal Chem 2012;26:383-9. [DOI: 10.1002/aoc.2878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
473 Valasoulis G, Stasinou SM, Nasioutziki M, Athanasiou A, Zografou M, Spathis A, Loufopoulos A, Karakitsos P, Paraskevaidis E, Kyrgiou M. Expression of HPV-related biomarkers and grade of cervical intraepithelial lesion at treatment. Acta Obstet Gynecol Scand 2014;93:194-200. [PMID: 24175665 DOI: 10.1111/aogs.12298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
474 Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter. 2014;19:425-436. [PMID: 25164596 DOI: 10.1111/hel.12150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
475 Ducena K, Abols A, Vilmanis J, Narbuts Z, Tārs J, Andrējeva D, Linē A, Pīrāgs V. Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules. Thyroid Res 2011;4:11. [PMID: 21707985 DOI: 10.1186/1756-6614-4-11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
476 Law MH, Macgregor S, Hayward NK. Melanoma Genetics: Recent Findings Take Us Beyond Well-Traveled Pathways. Journal of Investigative Dermatology 2012;132:1763-74. [DOI: 10.1038/jid.2012.75] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
477 Zaravinos A. An updated overview of HPV-associated head and neck carcinomas. Oncotarget 2014;5:3956-69. [PMID: 24970795 DOI: 10.18632/oncotarget.1934] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
478 Schrem H, Kurok M, Kaltenborn A, Vogel A, Walter U, Zachau L, Manns MP, Klempnauer J, Kleine M. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl. 2013;19:1252-1261. [PMID: 24106037 DOI: 10.1002/lt.23722] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
479 Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V. [Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008]. Gac Sanit. 2012;26:217-222. [PMID: 22361637 DOI: 10.1016/j.gaceta.2011.10.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
480 Mandato VD, Abrate M, De Iaco P, Pirillo D, Ciarlini G, Leoni M, Comerci G, Ventura A, Lenzi B, Amadori A, Rosati F, Martinello R, De Palma R, Ventura C, Belotti LM, Formisano D, La Sala GB; Gynecological Oncology Network of Emilia Romagna Region. Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management. J Ovarian Res 2013;6:19. [PMID: 23547941 DOI: 10.1186/1757-2215-6-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
481 Silva JFSD, Mattos IE, Aydos RD. Tendencies of mortality by prostate cancer in the states of the Central-West Region of Brazil, 1980 - 2011. Rev bras epidemiol 2014;17:395-406. [DOI: 10.1590/1809-4503201400020009eng] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
482 Torres A, Torres K, Paszkowski T, Jodłowska-Jędrych B, Radomański T, Książek A, Maciejewski R. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol 2011;32:769-76. [PMID: 21559780 DOI: 10.1007/s13277-011-0179-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
483 Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Li Volti G, Cardile V, Abraham NG, Sorrenti V. Effects of ellagic Acid on angiogenic factors in prostate cancer cells. Cancers (Basel) 2013;5:726-38. [PMID: 24216999 DOI: 10.3390/cancers5020726] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
484 Follet J, Corcos L, Baffet G, Ezan F, Morel F, Simon B, Le Jossic-Corcos C. The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis. Br J Cancer 2012;106:685-92. [PMID: 22294184 DOI: 10.1038/bjc.2012.6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
485 Hadoux J, Besse B, Planchard D. Cancers bronchiques des non-fumeurs : particularités épidémiologiques, thérapeutiques et moléculaires. La Presse Médicale 2011;40:371-8. [DOI: 10.1016/j.lpm.2011.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
486 Sipos F, Mũzes G, Patai AV, Fũri I, Péterfia B, Hollósi P, Molnár B, Tulassay Z. Genome-wide screening for understanding the role of DNA methylation in colorectal cancer. Epigenomics 2013;5:569-81. [PMID: 24059802 DOI: 10.2217/epi.13.52] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
487 Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, Zafra Poves M, García Hernández MR, Cuevas Tortosa E, Aliaga Baño Á, Castillo Guardiola V, Martínez Hernández P, Tovar Zapata I, Martínez Barba E, Ayala de la Peña F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers. Familial Cancer 2017;16:477-89. [DOI: 10.1007/s10689-017-9985-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
488 Di Lorenzo G, Buonerba C. Hypercastration in prostate cancer. Expert Rev Endocrinol Metab 2013;8:303-5. [PMID: 30736141 DOI: 10.1586/17446651.2013.811843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
489 Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D, Aslam T, Patanwala I, Gaggar S, Cole M, Sumpter K, Stewart S, Rose J, Hudson M, Manas D, Reeves HL. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol. 2014;60:110-117. [PMID: 23978719 DOI: 10.1016/j.jhep.2013.08.011] [Cited by in Crossref: 293] [Cited by in F6Publishing: 269] [Article Influence: 32.6] [Reference Citation Analysis]
490 Procopio G, Guadalupi V, Giganti MO, Mariani L, Salvioni R, Nicolai N, Capone F, Valdagni R, Bajetta E. Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration. BJU Int 2011;108:223-7. [PMID: 21078047 DOI: 10.1111/j.1464-410X.2010.09825.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
491 Zhang S, Wang Y, Zhang H, Sun C, Dang S, Liu M. Hydroxyphenyl Butanone Induces Cell Cycle Arrest through Inhibition of GSK3β in Colorectal Cancer. Biomed Res Int 2021;2021:9981815. [PMID: 34307685 DOI: 10.1155/2021/9981815] [Reference Citation Analysis]
492 Nelen V, Thys G, Hermans A, D’hooge K, Dourcy-belle-rose B, Coebergh J, Roobol M, Denis L. Interval cancers in the Antwerp European randomised study of screening for prostate cancer study, using a 6year screening interval. European Journal of Cancer 2010;46:3090-4. [DOI: 10.1016/j.ejca.2010.09.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
493 Izumi K, Mizokami A, Sugimoto K, Narimoto K, Kitagawa Y, Koh E, Namiki M. Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study. Prostate Cancer Prostatic Dis 2011;14:238-42. [DOI: 10.1038/pcan.2011.10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
494 Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Kornprat P, Stojakovic T, Avian A, Gerger A. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg 2014;208:210-4. [PMID: 24581872 DOI: 10.1016/j.amjsurg.2013.10.030] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
495 Liu X, Chai Y, Li J, Ren P, Liu M, Dai L, Qian W, Li W, Zhang JY. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Tumour Biol 2014;35:2661-7. [PMID: 24399648 DOI: 10.1007/s13277-013-1350-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
496 Xiao G, Wang Q, Li B, Wu X, Liao H, Ren Y, Ai N. MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2. Oncol Res 2018;26:1183-9. [PMID: 29321083 DOI: 10.3727/096504018X15151495109394] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
497 Lévy-Sitbon C, Barbe C, Granel-Brocard F, Lipsker D, Aubin F, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Le Clainche A, Dalle S, Bernard P, Grange F. Diagnosis and management of melanoma with regional lymph node metastases: a population-based study in France. J Eur Acad Dermatol Venereol 2013;27:1081-7. [PMID: 22845015 DOI: 10.1111/j.1468-3083.2012.04652.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
498 le Clercq CM, Winkens B, Bakker CM, Keulen ET, Beets GL, Masclee AA, Sanduleanu S. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest Endosc. 2015;82:325-333.e2. [PMID: 25843613 DOI: 10.1016/j.gie.2014.12.052] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
499 Jacobsen MG, Thomsen FB, Fode M, Bisbjerg R, Østergren PB. Results of 14 years of brachytherapy for localized prostate cancer in Denmark: the Herlev cohort. Scand J Urol 2018;52:164-8. [PMID: 29463165 DOI: 10.1080/21681805.2018.1438510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
500 Arasaradnam RP, McFarlane MJ, Ryan-Fisher C, Westenbrink E, Hodges P, Thomas MG, Chambers S, O’Connell N, Bailey C, Harmston C. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS One. 2014;9:e108750. [PMID: 25268885 DOI: 10.1371/journal.pone.0108750] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 10.9] [Reference Citation Analysis]
501 Chen W, Armstrong BK, Zheng R, Zhang S, Yu X, Clements M. Cancer burden in China: a Bayesian approach. BMC Cancer 2013;13:458. [PMID: 24093796 DOI: 10.1186/1471-2407-13-458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
502 Park JY, Vollset SE, Melse-boonstra A, Chajès V, Ueland PM, Slimani N. Dietary intake and biological measurement of folate: A qualitative review of validation studies. Mol Nutr Food Res 2013;57:562-81. [DOI: 10.1002/mnfr.201200105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
503 Jiang O, Zhou R, Wu D, Liu Y, Wu W, Cheng N. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis. Tumour Biol. 2013;34:1215-1224. [PMID: 23355335 DOI: 10.1007/s13277-013-0664-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
504 Birgisson H, Nielsen HJ, Christensen IJ, Glimelius B, Brünner N. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study. Eur J Cancer. 2010;46:3323-3331. [PMID: 20619633 DOI: 10.1016/j.ejca.2010.06.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
505 Haj Mohammad N, Hulshof MC, Bergman JJ, Geijsen D, Wilmink JW, van Berge Henegouwen MI, van Laarhoven HW. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma. BMC Cancer 2014;14:56. [PMID: 24485047 DOI: 10.1186/1471-2407-14-56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
506 Nitschke K, Erben P, Waldbillig F, Abdelhadi A, Weis C, Gottschalt M, Wahby S, Nuhn P, Boutros M, Michel MS, von Hardenberg J, Worst TS. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5. World J Urol 2020;38:637-45. [DOI: 10.1007/s00345-019-02651-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
507 Quidde J, Arnold D, Stein A. Clinical management of localized colon cancer with capecitabine. Clin Med Insights Oncol 2012;6:363-73. [PMID: 23170068 DOI: 10.4137/CMO.S8194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
508 van de Schans S, Wymenga A, van Spronsen D, Schouten H, Coebergh J, Janssen-heijnen M. Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Annals of Oncology 2012;23:1280-6. [DOI: 10.1093/annonc/mdr411] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
509 Crocetti E, De Angelis R, Buzzoni C, Mariotto A, Storm H, Colonna M, Zanetti R, Serraino D, Michiara M, Cirilli C, Iannelli A, Mazzoleni G, Sechi O, Sanoja Gonzalez ME, Guzzinati S, Capocaccia R, Dal Maso L; AIRTUM Working group. Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability. Br J Cancer 2013;109:219-28. [PMID: 23799856 DOI: 10.1038/bjc.2013.311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
510 Suriano F, Santini D, Perrone G, Amato M, Vincenzi B, Tonini G, Muda A, Boggia S, Buscarini M, Pantano F. Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer. J Exp Clin Cancer Res 2013;32:87. [PMID: 24423367 DOI: 10.1186/1756-9966-32-87] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
511 Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, Boffetta P, Dahm CC, Overvad K, Tjønneland A, Halkjaer J, Fagherazzi G, Boutron-ruault M, Carbonnel F, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Bamia C, Lagiou P, Palli D, Grioni S, Panico S, Tumino R, Vineis P, Hb B, van den Berg S, Peeters PH, Braaten T, Weiderpass E, Quirós JR, Travier N, Sánchez M, Navarro C, Barricarte A, Dorronsoro M, Lindkvist B, Regner S, Werner M, Sund M, Khaw K, Wareham N, Travis RC, Norat T, Wark PA, Riboli E, Nöthlings U. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2013;132:645-57. [DOI: 10.1002/ijc.27645] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 10.7] [Reference Citation Analysis]
512 Thum-umnuaysuk S, Boonyapibal A, Geng YY, Pattana-Arun J. Lengthening of the colon for low rectal anastomosis in a cadaveric study: how much can we gain? Tech Coloproctol 2013;17:377-81. [PMID: 23229559 DOI: 10.1007/s10151-012-0930-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
513 Larrinaga G, Perez I, Blanco L, Sanz B, Errarte P, Beitia M, Etxezarraga MC, Loizate A, Gil J, Irazusta J, López JI. Prolyl endopeptidase activity is correlated with colorectal cancer prognosis. Int J Med Sci 2014;11:199-208. [PMID: 24465166 DOI: 10.7150/ijms.7178] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
514 Di Lena M, Travaglio E, Altomare DF. New strategies for colorectal cancer screening. World J Gastroenterol 2013; 19(12): 1855-1860 [PMID: 23569331 DOI: 10.3748/wjg.v19.i12.1855] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
515 Neri A, Megha T, Bettarini F, Tacchini D, Mastrogiulio MG, Marrelli D, Pinto E, Tosi P. Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases. Hum Pathol 2012;43:1184-91. [PMID: 22397869 DOI: 10.1016/j.humpath.2011.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
516 van der Aalst CM, van Iersel CA, van Klaveren RJ, Frenken FJ, Fracheboud J, Otto SJ, de Jong PA, Oudkerk M, de Koning HJ. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role? Lung Cancer 2012;77:51-7. [PMID: 22459203 DOI: 10.1016/j.lungcan.2012.02.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
517 Álvarez-chaver P, Rodríguez-piñeiro AM, Rodríguez-berrocal FJ, García-lorenzo A, Páez de la Cadena M, Martínez-zorzano VS. Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate. Journal of Proteomics 2011;74:874-86. [DOI: 10.1016/j.jprot.2011.02.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
518 Drudge-coates L, Turner B. Prostate cancer overview. Part 1: non-metastatic disease. British Journal of Nursing 2012;21:S23-8. [DOI: 10.12968/bjon.2012.21.sup9.s23] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
519 Spindler KG, Appelt AL, Pallisgaard N, Andersen RF, Jakobsen A. KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer. Br J Cancer 2013;109:3067-72. [PMID: 24263065 DOI: 10.1038/bjc.2013.633] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
520 Chen CH, Lin CL, Kao CH. Association of Cholecystectomy with the Risk of Prostate Cancer in Patients with Gallstones. Cancers (Basel) 2020;12:E544. [PMID: 32120816 DOI: 10.3390/cancers12030544] [Reference Citation Analysis]
521 Mechref Y, Hu Y, Garcia A, Hussein A. Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis 2012;33:1755-67. [PMID: 22740464 DOI: 10.1002/elps.201100715] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 10.9] [Reference Citation Analysis]
522 Javed S, Chadwick E, Edwards AA, Beveridge S, Laing R, Bott S, Eden C, Langley S. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int 2014;114:541-8. [PMID: 24224648 DOI: 10.1111/bju.12568] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
523 Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, Müllauer L, Gnant M, Scheithauer W, Pabinger I. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 2013;43:277-85. [PMID: 23398637 DOI: 10.1111/eci.12042] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
524 Giesinger JM, Wintner LM, Oberguggenberger AS, Gamper EM, Fiegl M, Denz H, Kemmler G, Zabernigg A, Holzner B. Quality of life trajectory in patients with advanced cancer during the last year of life. J Palliat Med 2011;14:904-12. [PMID: 21711125 DOI: 10.1089/jpm.2011.0086] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
525 Moul JW, Dawson N. Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature. Cancer Investigation 2012;30:1-12. [DOI: 10.3109/07357907.2011.629381] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
526 Mesía R, Rueda A, Vera R, Lozano A, Medina JA, Aguiar D, Árias F, Triana G, Carles J, López-López R. Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol 2013;24:448-53. [PMID: 23041591 DOI: 10.1093/annonc/mds291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
527 Schröder FH, Denis L, Roobol MJ. Epilogue: Different approaches for prostate cancer screening in the EU? European Journal of Cancer 2010;46:3120-5. [DOI: 10.1016/j.ejca.2010.09.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
528 Al-haidari AA, Syk I, Jirström K, Thorlacius H. CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling. Int J Colorectal Dis 2013;28:1479-87. [PMID: 23649168 DOI: 10.1007/s00384-013-1712-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
529 Groothuis-Oudshoorn CG, Fermont JM, van Til JA, Ijzerman MJ. Public stated preferences and predicted uptake for genome-based colorectal cancer screening. BMC Med Inform Decis Mak 2014;14:18. [PMID: 24642027 DOI: 10.1186/1472-6947-14-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
530 Bray F, Lortet-tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: An overview. European Journal of Cancer 2010;46:3040-52. [DOI: 10.1016/j.ejca.2010.09.013] [Cited by in Crossref: 205] [Cited by in F6Publishing: 294] [Article Influence: 17.1] [Reference Citation Analysis]
531 van den Bosch S, Alfred Witjes J. Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review. European Urology 2011;60:493-500. [DOI: 10.1016/j.eururo.2011.05.045] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 14.7] [Reference Citation Analysis]
532 Svobodova M, Bunka DH, Nadal P, Stockley PG, O'Sullivan CK. Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications. Anal Bioanal Chem 2013;405:9149-57. [PMID: 24043377 DOI: 10.1007/s00216-013-7350-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
533 Esseridou A, Di Leo G, Sconfienza LM, Caldiera V, Raspagliesi F, Grijuela B, Hanozet F, Podo F, Sardanelli F. In Vivo Detection of Choline in Ovarian Tumors Using 3D Magnetic Resonance Spectroscopy: . Investigative Radiology 2011;46:377-82. [DOI: 10.1097/rli.0b013e31821690ef] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
534 Dauwen H, Van Calster B, Deroose C, Op de Beeck K, Amant F, Neven P, Berteloot P, Leunen K, Timmerman D, Vergote I. PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer. Gynecologic Oncology 2013;131:694-700. [DOI: 10.1016/j.ygyno.2013.08.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
535 Bentmar Holgersson M, Ruhayel Y, Karlsson M, Giwercman A, Bjartell A, Ohlsson C, Mellström D, Ljunggren Ö, Haghsheno MA, Damber JE, Lundberg Giwercman Y. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele. Cancer Causes Control 2017;28:227-33. [PMID: 28176139 DOI: 10.1007/s10552-017-0859-1] [Reference Citation Analysis]
536 Grassi P, Verzoni E, Mariani L, De Braud F, Coppa J, Mazzaferro V, Procopio G. Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center. Clin Genitourin Cancer 2013;11:484-8. [PMID: 23791435 DOI: 10.1016/j.clgc.2013.04.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
537 Netter J, Lehmann-Che J, Lambert J, Tallet A, Lourenco N, Soliman H, Bertheau P, Pariente B, Chirica M, Pocard M, Allez M, De The H, Gornet JM. Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer. Bull Cancer 2015;102:117-25. [PMID: 25609485 DOI: 10.1016/j.bulcan.2014.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
538 Gu J, Wang B, Liu Y, Zhong L, Tang Y, Guo H, Jiang T, Wang L, Li Y, Cai L. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo. Eur J Cancer 2014;50:1184-94. [PMID: 24447832 DOI: 10.1016/j.ejca.2013.12.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
539 Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631-639. [PMID: 21106365 DOI: 10.1016/j.ejca.2010.10.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
540 Yang Y, Wang F, Shi C, Zou Y, Qin H, Ma Y. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies. PLoS One 2012;7:e36813. [PMID: 22606291 DOI: 10.1371/journal.pone.0036813] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
541 Brome Bohórquez MR, Montoya Restrepo DM, Amell L. Cancer incidence and mortality in Medellin-Colombia, 2010-2014. Colomb Med (Cali) 2018;49:81-8. [PMID: 29983467 DOI: 10.25100/cm.v49i1.3740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
542 Gabaldó Barrios X, Sarabia Meseguer MD, Alonso Romero JL, Marín Vera M, Marín Zafra G, Sánchez Henarejos P, Sánchez Bermúdez AI, Ruiz Espejo F. Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry. Fam Cancer 2014;13:431-5. [PMID: 24633894 DOI: 10.1007/s10689-014-9708-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
543 Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, Kilic S, Cetin M, Erdemir S, Navio MS, Lopez MA, Curtis N, Yagci T, Primrose JN, Price BD, Berx G, Thomas GJ, Tulchinsky E, Mirnezami A, Sayan AE. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol Oncol 2021;15:2065-83. [PMID: 33931939 DOI: 10.1002/1878-0261.12965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
544 Torres-Roman JS, Ronceros-Cardenas L, Valcarcel B, Arce-Huamani MA, Bazalar-Palacios J, Ybaseta-Medina J, La Vecchia C, Alvarez CS. Cervical cancer mortality in Peru: regional trend analysis from 2008-2017. BMC Public Health 2021;21:219. [PMID: 33499858 DOI: 10.1186/s12889-021-10274-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
545 Tsouknidas I, Tasis N, Kokkinos C, Trihia H, Filippou D, Skandalakis P, Troupis T. A very rare case of renal cell carcinoma metastasis to spermatic cord and a condensed literature review. Int J Surg Case Rep 2018;53:508-12. [PMID: 29456040 DOI: 10.1016/j.ijscr.2017.12.027] [Reference Citation Analysis]
546 Beaver K, Campbell M, Williamson S, Procter D, Sheridan J, Heath J, Susnerwala S. An exploratory randomized controlled trial comparing telephone and hospital follow-up after treatment for colorectal cancer. Colorectal Dis 2012;14:1201-9. [PMID: 22230203 DOI: 10.1111/j.1463-1318.2012.02936.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
547 García-González MA, Lanas A. Genetic susceptibility and gastric cancer risk: the importance of meta-analyses as a statistical tool. Gastroenterol Hepatol. 2014;37:421-426. [PMID: 24661935 DOI: 10.1016/j.gastrohep.2014.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
548 Warneke VS, Behrens HM, Hartmann JT, Held H, Becker T, Schwarz NT, Röcken C. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol. 2011;29:2364-2371. [PMID: 21537040 DOI: 10.1200/jco.2010.34.4358] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
549 Doufekas K, Olaitan A. Clinical epidemiology of epithelial ovarian cancer in the UK. Int J Womens Health 2014;6:537-45. [PMID: 24920935 DOI: 10.2147/IJWH.S40894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
550 Asadi P, Khodarahmi G, Farrokhpour H, Hassanzadeh F, Saghaei L. Quantum mechanical/molecular mechanical and docking study of the novel analogues based on hybridization of common pharmacophores as potential anti-breast cancer agents. Res Pharm Sci 2017;12:233-40. [PMID: 28626481 DOI: 10.4103/1735-5362.207204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
551 Bedard PL, Cardoso F. Can some patients avoid adjuvant chemotherapy for early-stage breast cancer? Nat Rev Clin Oncol 2011;8:272-9. [DOI: 10.1038/nrclinonc.2011.19] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
552 Ouzaid I, Xylinas E, Pignot G, Tardieu A, Hoznek A, Abbou CC, de la Taille A, Salomon L. Laparoscopic partial nephrectomy: is it worth still performing the retroperitoneal route? Adv Urol 2012;2012:473457. [PMID: 22754565 DOI: 10.1155/2012/473457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
553 Cusumano P, Generali D, Ciruelos E, Manso L, Ghanem I, Lifrange E, Jerusalem G, Klaase J, de Snoo F, Stork-sloots L, Dekker-vroling L, Holzik ML. European inter-institutional impact study of MammaPrint. The Breast 2014;23:423-8. [DOI: 10.1016/j.breast.2014.02.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
554 Rothschild SI. Epigenetic Therapy in Lung Cancer - Role of microRNAs. Front Oncol. 2013;3:158. [PMID: 23802096 DOI: 10.3389/fonc.2013.00158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
555 García-Barreras S, Nunes I, Srougi V, Secin F, Baghdadi M, Sánchez-Salas R, Barret E, Rozet F, Galiano M, Cathelineau X. Predictors of early, intermediate and late biochemical recurrence after minimally invasive radical prostatectomy in a single-centre cohort with a mean follow-up of 8 years. Actas Urol Esp (Engl Ed) 2018;42:516-23. [PMID: 29606285 DOI: 10.1016/j.acuro.2018.02.004] [Reference Citation Analysis]
556 Al-Menhali A, Al-Rumaihi A, Al-Mohammed H, Al-Mazrooey H, Al-Shamlan M, AlJassim M, Al-Korbi N, Eid AH. Thymus vulgaris (thyme) inhibits proliferation, adhesion, migration, and invasion of human colorectal cancer cells. J Med Food 2015;18:54-9. [PMID: 25379783 DOI: 10.1089/jmf.2013.3121] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
557 Hummel JM, Steuten LG, Groothuis-Oudshoorn CJ, Mulder N, Ijzerman MJ. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy 2013;11:499-507. [PMID: 23979875 DOI: 10.1007/s40258-013-0051-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
558 Simard JF, Baecklund F, Chang ET, Baecklund E, Hjalgrim H, -Olov Adami H, Glimelius B, Smedby KE. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes. Int J Cancer 2013;132:2659-66. [PMID: 23160780 DOI: 10.1002/ijc.27944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
559 Hrbacek J, Urban M, Hamsikova E, Tachezy R, Heracek J. Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urol Oncol. 2013;31:951-965. [PMID: 22459691 DOI: 10.1016/j.urolonc.2012.01.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
560 Harju E, Rantanen A, Helminen M, Kaunonen M, Isotalo T, Åstedt‐kurki P. Marital relationship and health‐related quality of life of patients with prostate cancer and their spouses: A longitudinal clinical study. J Clin Nurs 2018;27:2633-9. [DOI: 10.1111/jocn.14343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
561 Gong X, Ma C, Yang P, Chen Y, Du C, Fu C, Lu JP. Computer-aided pancreas segmentation based on 3D GRE Dixon MRI: a feasibility study. Acta Radiol Open 2019;8:2058460119834690. [PMID: 30944729 DOI: 10.1177/2058460119834690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
562 Dowell AC, Oldham KA, Bhatt RI, Lee SP, Searle PF. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12. Cancer Immunol Immunother. 2012;61:615-628. [PMID: 22021067 DOI: 10.1007/s00262-011-1122-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
563 Yan L, You WQ, Sheng NQ, Gong JF, Hu LD, Tan GW, Chen HQ, Wang ZG. A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer. Aging (Albany NY) 2018;10:3774-93. [PMID: 30523220 DOI: 10.18632/aging.101671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
564 Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Wright AJ, Barentsz JO, Heerschap A, Scheenen TW. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Eur Urol 2011;60:1074-80. [PMID: 21419565 DOI: 10.1016/j.eururo.2011.03.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
565 Cipolletta L, Rotondano G, Bianco MA, Buffoli F, Gizzi G, Tessari F. Endoscopic resection for superficial colorectal neoplasia in Italy: a prospective multicentre study. Dig Liver Dis. 2014;46:146-151. [PMID: 24183949 DOI: 10.1016/j.dld.2013.09.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
566 Tessier P, Lelorain S, Bonnaud-antignac A. A comparison of the clinical determinants of health-related quality of life and subjective well-being in long-term breast cancer survivors: QoL in long-term breast cancer survivors. European Journal of Cancer Care 2012;21:692-700. [DOI: 10.1111/j.1365-2354.2012.01344.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
567 Mrozikiewicz-Rakowska B, Malinowski M, Nehring P, Bartkowiak-Wieczorek J, Bogacz A, Żurawińska-Grzelka E, Krasnodębski P, Muszyński J, Grzela T, Przybyłkowski A, Czupryniak L. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Arch Med Sci 2020;16:112-7. [PMID: 32051713 DOI: 10.5114/aoms.2017.70329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
568 Van Esch L, Roukema JA, Ernst MF, Nieuwenhuijzen GA, De Vries J. Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord 2012;136:895-901. [PMID: 21975139 DOI: 10.1016/j.jad.2011.09.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
569 Raijmakers NJH, van Zuylen L, Furst CJ, Beccaro M, Maiorana L, Pilastri P, Rossi C, Flego G, van der Heide A, Costantini M. Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer 2013;21:1003-11. [DOI: 10.1007/s00520-012-1619-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
570 Daudén E, Castañeda S, Suárez C, García-campayo J, Blasco A, Aguilar M, Ferrándiz C, Puig L, Sánchez-carazo J. Integrated Approach to Comorbidity in Patients With Psoriasis. Actas Dermo-Sifiliográficas (English Edition) 2012;103:1-64. [DOI: 10.1016/s1578-2190(12)70829-6] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
571 Salguero FJ, Belderbos JS, Rossi MM, Blaauwgeers JL, Stroom J, Sonke J. Microscopic disease extensions as a risk factor for loco-regional recurrence of NSCLC after SBRT. Radiotherapy and Oncology 2013;109:26-31. [DOI: 10.1016/j.radonc.2013.08.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
572 Procopciuc LM, Osian G. GSTM1-null Genotype as a Risk Factor for Sporadic Colorectal Cancer in a Romanian Population. Association with the NAT2-rapid-acetylator Phenotype and Exposure to Environmental Factors. Cancer Investigation 2013;32:53-62. [DOI: 10.3109/07357907.2013.867972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
573 Thorstenson A, Bergman M, Scherman-plogell A, Hosseinnia S, Ljungberg B, Adolfsson J, Lundstam S. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register. Scandinavian Journal of Urology 2014;48:231-8. [DOI: 10.3109/21681805.2013.864698] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
574 Eure G, Fanney D, Lin J, Wodlinger B, Ghai S. Comparison of conventional transrectal ultrasound, magnetic resonance imaging, and micro-ultrasound for visualizing prostate cancer in an active surveillance population: A feasibility study. Can Urol Assoc J 2019;13:E70-7. [PMID: 30169149 DOI: 10.5489/cuaj.5361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
575 Bosch-Barrera J, García-Franco C, Guillén-Grima F, Moreno-Jiménez M, López-Picazo JM, Gúrpide A, Pérez-Gracia JL, Aristu J, Torre W, García-Foncillas J, Gil-Bazo I. The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution's experience. Clin Transl Oncol 2012;14:835-41. [PMID: 22855163 DOI: 10.1007/s12094-012-0874-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
576 Allegra E, Trapasso S. Cancer stem cells in head and neck cancer. Onco Targets Ther. 2012;5:375-383. [PMID: 23189032 DOI: 10.2147/ott.s38694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
577 Sun D, Andayani TM, Altyar A, MacDonald K, Abraham I. Potential cost savings from chemotherapy-induced febrile neutropenia with biosimilar filgrastim and expanded access to targeted antineoplastic treatment across the European Union G5 countries: a simulation study. Clin Ther 2015;37:842-57. [PMID: 25704107 DOI: 10.1016/j.clinthera.2015.01.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
578 Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, Reza Makhsosi B, Salehiniya H. Colorectal cancer in Iran: Epidemiology and morphology trends. EXCLI J 2016;15:738-44. [PMID: 28337105 DOI: 10.17179/excli2016-346] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
579 Takata M, Chikumi H, Matsunami K, Kodani M, Sakamoto T, Hashimoto K, Nakamoto M, Okada K, Kitaura T, Matsumoto S, Kurai J, Yamasaki A, Igishi T, Burioka N, Shimizu E. A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncol Rep 2015;33:1040-8. [PMID: 25591975 DOI: 10.3892/or.2015.3716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
580 Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, Mongiat-Artus P. Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 2010;58:701-10. [PMID: 20817385 DOI: 10.1016/j.eururo.2010.08.031] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
581 Zhong R, Han B, Zhong H. A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients. Tumour Biol. 2014;35:987-994. [PMID: 24006222 DOI: 10.1007/s13277-013-1132-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
582 Peickert S, Waurig J, Dittfeld C, Dietrich A, Garbe Y, Kabus L, Baumann M, Grade M, Ried T, Kunz-Schughart LA. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo. Lab Invest 2012;92:1607-22. [PMID: 22964855 DOI: 10.1038/labinvest.2012.124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
583 Zhou Y, Wang YN, Farr N, Zia J, Chen H, Ko BM, Khokhlova T, Li T, Hwang JH. Enhancement of Small Molecule Delivery by Pulsed High-Intensity Focused Ultrasound: A Parameter Exploration. Ultrasound Med Biol 2016;42:956-63. [PMID: 26803389 DOI: 10.1016/j.ultrasmedbio.2015.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
584 Rioja J, Morcillo E, Novalbos JP, Sánchez-hurtado MA, Soria F, Pérez-duarte F, Díaz-güemes Martín-portugüés I, Laguna MP, Sánchez-margallo FM, Rodríguez-rubio Cortadellas F. Laparoscopic Partial Nephrectomy With Potassium-titanyl-phosphate Laser Versus Conventional Laparoscopic Partial Nephrectomy: An Animal Randomized Controlled Trial. Urology 2017;99:123-30. [DOI: 10.1016/j.urology.2016.03.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
585 Landrigan PJ, Espina C, Neira M. Global prevention of environmental and occupational cancer. Environ Health Perspect 2011;119:A280-1. [PMID: 21719377 DOI: 10.1289/ehp.1103871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
586 Soylu H, Acar N, Ozbey O, Unal B, Koksal IT, Bassorgun I, Ciftcioglu A, Ustunel I. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma. Pathol Oncol Res 2016;22:87-94. [PMID: 26341090 DOI: 10.1007/s12253-015-9983-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
587 Prados J, Melguizo C, Roldan H, Alvarez PJ, Ortiz R, Arias JL, Aranega A. RNA interference in the treatment of colon cancer. BioDrugs. 2013;27:317-327. [PMID: 23553339 DOI: 10.1007/s40259-013-0019-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
588 Chen PY, Chang H. The coping process of patients with cancer. European Journal of Oncology Nursing 2012;16:10-6. [DOI: 10.1016/j.ejon.2011.01.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
589 Laga T, Lambrechts S, Laenen A, Van Nieuwenhuysen E, Han SN, Vergote I. Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery. Int J Gynecol Cancer 2018;28:721-8. [PMID: 29561300 DOI: 10.1097/IGC.0000000000001219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
590 Denis H, Van Grembergen O, Delatte B, Dedeurwaerder S, Putmans P, Calonne E, Rothé F, Sotiriou C, Fuks F, Deplus R. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. Mol BioSyst 2016;12:404-13. [DOI: 10.1039/c5mb00513b] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
591 Rack B, Andergassen U, Neugebauer J, Salmen J, Hepp P, Sommer H, Lichtenegger W, Friese K, Beckmann MW, Hauner D, Hauner H, Janni W. The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer. Breast Care (Basel) 2010;5:395-400. [PMID: 21494405 DOI: 10.1159/000322677] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
592 Justino CI, Rocha-santos TA, Duarte AC, Rocha-santos TA. Advances in point-of-care technologies with biosensors based on carbon nanotubes. TrAC Trends in Analytical Chemistry 2013;45:24-36. [DOI: 10.1016/j.trac.2012.12.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
593 Larne O, Hagman Z, Lilja H, Bjartell A, Edsjö A, Ceder Y. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. Carcinogenesis 2015;36:858-66. [PMID: 25969144 DOI: 10.1093/carcin/bgv063] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
594 De Smet L, Colin P, Ceelen W, Bracke M, Van Bocxlaer J, Remon JP, Vervaet C. Development of a Nanocrystalline Paclitaxel Formulation for Hipec Treatment. Pharm Res 2012;29:2398-406. [DOI: 10.1007/s11095-012-0765-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
595 Roberts CM, Shahin SA, Loeza J, Dellinger TH, Williams JC, Glackin CA. Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target. BMC Cancer 2017;17:184. [PMID: 28283022 DOI: 10.1186/s12885-017-3169-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
596 Qiao W, Wang T, Zhang L, Tang Q, Wang D, Sun H. Association between single genetic polymorphisms of MDR1 gene and gastric cancer susceptibility in Chinese. Med Oncol 2013;30:643. [PMID: 23801278 DOI: 10.1007/s12032-013-0643-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
597 Shaikh MH, Clarke DTW, Johnson NW, McMillan NAJ. Can gene editing and silencing technologies play a role in the treatment of head and neck cancer? Oral Oncol 2017;68:9-19. [PMID: 28438299 DOI: 10.1016/j.oraloncology.2017.02.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
598 Ayude D, Rodríguez-Berrocal FJ, Ayude J, Blanco-Prieto S, Vázquez-Iglesias L, Vázquez-Cedeira M, Páez de la Cadena M. Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer. BMC Cancer 2013;13:543. [PMID: 24215576 DOI: 10.1186/1471-2407-13-543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
599 Burada F, Dumitrescu T, Nicoli R, Ciurea ME, Angelescu C, Mixich F, Ioana M. IL-1RN +2018T>C polymorphism is correlated with colorectal cancer. Mol Biol Rep. 2013;40:2851-2857. [PMID: 23192617 DOI: 10.1007/s11033-012-2300-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
600 Regier M, Chun F. Thermal Ablation of Renal Tumors: Indications, Techniques and Results. Dtsch Arztebl Int 2015;112:412-8. [PMID: 26159218 DOI: 10.3238/arztebl.2015.0412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
601 Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479-2516. [PMID: 23012255 DOI: 10.1093/annonc/mds236] [Cited by in Crossref: 877] [Cited by in F6Publishing: 791] [Article Influence: 97.4] [Reference Citation Analysis]
602 Felgueiras J, Silva JV, Fardilha M. Prostate cancer: the need for biomarkers and new therapeutic targets. J Zhejiang Univ Sci B. 2014;15:16-42. [PMID: 24390742 DOI: 10.1631/jzus.b1300106] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
603 Aiello VD, Tanigawa RY, Chate RC, de Campos FPF, Mansur AJ. Progressive dyspnea and a right atrial mass in an 80-year-old man. Autops Case Rep 2019;9:e2019135. [PMID: 31807438 DOI: 10.4322/acr.2019.135] [Reference Citation Analysis]
604 Vergote IB, Jimeno A, Joly F, Katsaros D, Coens C, Despierre E, Marth C, Hall M, Steer CB, Colombo N, Lesoin A, Casado A, Reinthaller A, Green J, Buck M, Ray-Coquard I, Ferrero A, Favier L, Reed NS, Curé H, Pujade-Lauraine E. Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study. J Clin Oncol 2014;32:320-6. [PMID: 24366937 DOI: 10.1200/JCO.2013.50.5669] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
605 Meoni G, Cecere FL, Lucherini E, Di Costanzo F. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents. J Geriatr Oncol. 2013;4:282-290. [PMID: 24070465 DOI: 10.1016/j.jgo.2013.04.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
606 Rosales-Reynoso MA, Arredondo-Valdez AR, Wence-Chávez LI, Barros-Núñez P, Gallegos-Arreola MP, Flores-Martínez SE, Sánchez-Corona J. AXIN2 Polymorphisms and Their Association with Colorectal Cancer in Mexican Patients. Genet Test Mol Biomarkers 2016;20:438-44. [PMID: 27228364 DOI: 10.1089/gtmb.2016.0026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
607 Westenbrink E, Arasaradnam RP, O'Connell N, Bailey C, Nwokolo C, Bardhan KD, Covington JA. Development and application of a new electronic nose instrument for the detection of colorectal cancer. Biosens Bioelectron 2015;67:733-8. [PMID: 25465796 DOI: 10.1016/j.bios.2014.10.044] [Cited by in Crossref: 75] [Cited by in F6Publishing: 52] [Article Influence: 9.4] [Reference Citation Analysis]
608 Wang T, Wu Y, Zhou H, Wu C, Zhang X, Chen Y, Zhao D. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation. BMC Gastroenterol 2021;21:38. [PMID: 33499821 DOI: 10.1186/s12876-021-01618-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
609 Barral M, Auperin A, Hakime A, Cartier V, Tacher V, Otmezguine Y, Tselikas L, de Baere T, Deschamps F. Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients. Cardiovasc Intervent Radiol 2016;39:885-93. [DOI: 10.1007/s00270-016-1301-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
610 Pottel L, Lycke M, Boterberg T, Foubert I, Pottel H, Duprez F, Goethals L, Debruyne PR. Omega-3 fatty acids: physiology, biological sources and potential applications in supportive cancer care. Phytochem Rev 2014;13:223-44. [DOI: 10.1007/s11101-013-9309-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
611 Gonnissen A, Isebaert S, McKee CM, Dok R, Haustermans K, Muschel RJ. The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo. Oncotarget 2016;7:84286-98. [PMID: 27713179 DOI: 10.18632/oncotarget.12483] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
612 Liao Y, Ni Y, He R, Liu W, Du J. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis. J Cancer Res Clin Oncol 2013;139:1523-8. [DOI: 10.1007/s00432-013-1471-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
613 Dimopoulos MA, San-Miguel JF, Anderson KC. Emerging therapies for the treatment of relapsed or refractory multiple myeloma. Eur J Haematol 2011;86:1-15. [PMID: 20942854 DOI: 10.1111/j.1600-0609.2010.01542.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
614 Xing J, Myers RE, He X, Qu F, Zhou F, Ma X, Hyslop T, Bao G, Wan S, Yang H, Chen Z. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer 2011;47:1699-707. [PMID: 21402474 DOI: 10.1016/j.ejca.2011.02.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
615 Liu Z, Zhang W, Fan S, Wang L, Jiao L. Changes in the electron paramagnetic resonance spectra of albumin-associated spin-labeled stearic acid as a diagnostic parameter of colorectal cancer. World J Surg Oncol 2013;11:223. [PMID: 24025321 DOI: 10.1186/1477-7819-11-223] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
616 Borda A, Sanz B, Otero L, Blasco T, García-Gómez FJ, de Andrés F. [Travel time and participation in breast cancer screening in a region with high population dispersion]. Gac Sanit 2011;25:151-6. [PMID: 21334790 DOI: 10.1016/j.gaceta.2010.10.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
617 Guglieri-López B, Pérez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, Climente-Martí M, Alós-Almiñana M. Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting. Anticancer Drugs 2015;26:860-5. [PMID: 25919319 DOI: 10.1097/CAD.0000000000000240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
618 Mastrangelo G, Carta A, Arici C, Pavanello S, Porru S. An etiologic prediction model incorporating biomarkers to predict the bladder cancer risk associated with occupational exposure to aromatic amines: a pilot study. J Occup Med Toxicol 2017;12:23. [PMID: 28804505 DOI: 10.1186/s12995-017-0167-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
619 Duggan ST, Keating GM. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs 2011;71:2531-58. [PMID: 22141391 DOI: 10.2165/11207510-000000000-00000] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 14.6] [Reference Citation Analysis]
620 Gnant M, Balic M, Petru E, Raunik W, Singer CF, Steger GG, Watzke IM, Brodowicz T. Treatment of Bone Metastases in Patients with Advanced Breast Cancer. Breast Care (Basel) 2012;7:92-8. [PMID: 22740794 DOI: 10.1159/000338650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
621 Shaheen E, Van Ongeval C, Zanca F, Cockmartin L, Marshall N, Jacobs J, Young KC, R Dance D, Bosmans H. The simulation of 3D microcalcification clusters in 2D digital mammography and breast tomosynthesis. Med Phys 2011;38:6659-71. [PMID: 22149848 DOI: 10.1118/1.3662868] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
622 Tribius S, Ihloff AS, Rieckmann T, Petersen C, Hoffmann M. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett 2011;304:71-9. [PMID: 21376458 DOI: 10.1016/j.canlet.2011.02.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
623 Stauffer PR, van Rhoon GC. Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperthermia 2016;32:407-16. [PMID: 26939993 DOI: 10.3109/02656736.2016.1141239] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
624 Nordin A, Wang W, Welén K, Damber J. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer: Midkine in PC Neuroendocrine Differentiation. Prostate 2013;73:657-67. [DOI: 10.1002/pros.22607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
625 Elsen S, Lerut E, Van Cleynenbreugel B, van der Aa F, van Poppel H, de Witte PA. Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy. BJU Int 2015;116:468-77. [PMID: 25754262 DOI: 10.1111/bju.13113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
626 Hernando-Cubero J, Matos-García I, Alonso-Orduña V, Capdevila J. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed. J Gastrointest Cancer 2017;48:135-47. [PMID: 28397102 DOI: 10.1007/s12029-017-9946-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
627 Söder B, Andersson LC, Meurman JH, Söder PÖ. Unique database study linking gingival inflammation and smoking in carcinogenesis. Philos Trans R Soc Lond B Biol Sci 2015;370:20140041. [PMID: 25533098 DOI: 10.1098/rstb.2014.0041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
628 Sadowska A, Kędra B, Cepowicz D, Rodziewicz L, Fiedorowicz A, Prokopiuk S, Miltyk W, Car H. Increased concentration of metronidazole and its hydroxy metabolite in colon cancer in women. Pharmacological Reports 2012;64:1276-80. [DOI: 10.1016/s1734-1140(12)70924-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
629 Guichard J, Garet M, Auberdiac P, Nourissat A, Roche F, Mélis A, Barthélémy J, Chauvin F, Da Costa A, Chargari C, Merrouche Y, Jacquin J, Collard O, Magné N. Quantification de l’activité physique journalière des patientes traitées pour un cancer du sein et comparaison avec deux populations témoins. Bulletin du Cancer 2011;98:733-40. [DOI: 10.1684/bdc.2011.1393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
630 Sonehara NM, Lacerda JZ, Jardim-Perassi BV, de Paula Jr R Jr, Moschetta-Pinheiro MG, Souza YST, de Andrade JCJ, De Campos Zuccari DAP. Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines. Oncol Lett 2019;17:1635-45. [PMID: 30675223 DOI: 10.3892/ol.2018.9758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
631 Burns RM, Sharp L, Sullivan FJ, Deady SE, Drummond FJ, O Neill C. Factors driving inequality in prostate cancer survival: a population based study. PLoS One 2014;9:e106456. [PMID: 25203444 DOI: 10.1371/journal.pone.0106456] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
632 Boureau AS, Bourbouloux E, Retornaz F, Berrut G, de Decker L. Effect of burden of comorbidity on optimal breast cancer treatment in older adults. J Am Geriatr Soc 2012;60:2368-70. [PMID: 23231558 DOI: 10.1111/jgs.12013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
633 Trobec K, Knez L, Meško Brguljan P, Cufer T, Lainščak M. Estimation of renal function in lung cancer patients. Lung Cancer 2012;76:397-402. [PMID: 22177534 DOI: 10.1016/j.lungcan.2011.11.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
634 Hachemi M, Couturier O, Vervueren L, Fosse P, Lacœuille F, Urban T, Hureaux J. [¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients. PLoS One 2014;9:e87629. [PMID: 24505298 DOI: 10.1371/journal.pone.0087629] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
635 Szkandera J, Herzog S, Pichler M, Stiegelbauer V, Stotz M, Schaberl-Moser R, Samonigg H, Asslaber M, Lax S, Leitner G, Renner W, Lenz HJ, Berghold A, Gerger A. LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy. Pharmacogenomics J 2015;15:391-6. [PMID: 25665511 DOI: 10.1038/tpj.2015.2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
636 Shrivastava P, Garg H, Bhat M, Dinda A, Kumar R. Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study. Indian J Urol 2020;36:50-5. [PMID: 31983827 DOI: 10.4103/iju.IJU_202_19] [Reference Citation Analysis]
637 Moreno-Alarcón C, Ramírez-Backhaus M, Pelechano-Gómez P, Ortiz-Rodríguez IM, Rubio-Briones J, Rodríguez-Torreblanca C, Solsona-Narbón E. Nephrometry scores: interobserver reproducibility and perioperative factors prediction. Actas Urol Esp 2014;38:523-9. [PMID: 24703257 DOI: 10.1016/j.acuro.2014.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
638 Kunze D, Kraemer K, Erdmann K, Froehner M, Wirth MP, Fuessel S. Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int J Oncol 2012;41:1271-7. [PMID: 22797576 DOI: 10.3892/ijo.2012.1549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
639 Ribrag V, Caballero D, Fermé C, Zucca E, Arranz R, Briones J, Gisselbrecht C, Salles G, Gianni AM, Gomez H, Kahatt C, Corrado C, Szyldergemajn S, Extremera S, de Miguel B, Cullell-Young M, Cavalli F. Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma. Haematologica 2013;98:357-63. [PMID: 23065525 DOI: 10.3324/haematol.2012.069757] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
640 Wu H, Li X, Liu W, Chen T, Li Y, Zheng W, Man CW, Wong M, Wong K. Surface decoration of selenium nanoparticles by mushroom polysaccharides–protein complexes to achieve enhanced cellular uptake and antiproliferative activity. J Mater Chem 2012;22:9602. [DOI: 10.1039/c2jm16828f] [Cited by in Crossref: 95] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
641 Lövgren M, Wilde-larsson B, Hök J, Leveälahti H, Tishelman C. Push or pull? Relationships between lung cancer patients’ perceptions of quality of care and use of complementary and alternative medicine. European Journal of Oncology Nursing 2011;15:311-7. [DOI: 10.1016/j.ejon.2010.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
642 Taylor S, Bellhouse S, Allsop M, Radford J, Yorke J. The Role of e-Health in the Delivery of Care for Patients with Hematological Cancers: A Systematic Literature Review. Telemedicine and e-Health 2020;26:1093-105. [DOI: 10.1089/tmj.2019.0231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
643 Rizzotto G, Crosetti E, Lucioni M, Succo G. Subtotal laryngectomy: outcomes of 469 patients and proposal of a comprehensive and simplified classification of surgical procedures. Eur Arch Otorhinolaryngol 2012;269:1635-46. [DOI: 10.1007/s00405-012-1928-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
644 Holme Ø, Bretthauer M, Fretheim A, Odgaard-jensen J, Hoff G; Cochrane Colorectal Cancer Group. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd009259.pub2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
645 Mokhles S, Nuyttens JJ, Maat APWM, Birim Ö, Aerts JGJV, Bogers AJJC, Takkenberg JJM. Survival and Treatment of Non-small Cell Lung Cancer Stage I–II Treated Surgically or with Stereotactic Body Radiotherapy: Patient and Tumor-Specific Factors Affect the Prognosis. Ann Surg Oncol 2015;22:316-23. [DOI: 10.1245/s10434-014-3860-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
646 Sboui M, Bouattour S, Boufi S. Functionalization of cotton fibers with hierarchical flower-like Na2Ti3O7/Ag layer. Cellulose 2020;27:2887-99. [DOI: 10.1007/s10570-020-02975-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
647 Schulz C, Häfner HM, Breuninger H, Leiter U. [Local recurrence and survival in acral lentiginous melanoma comparing 3D histology and conventional histology]. J Dtsch Dermatol Ges 2014;12:881-90. [PMID: 25262892 DOI: 10.1111/ddg.12448_suppl] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
648 Perrotta C, Buonanno F, Zecchini S, Giavazzi A, Proietti Serafini F, Catalani E, Guerra L, Belardinelli MC, Picchietti S, Fausto AM, Giorgi S, Marcantoni E, Clementi E, Ortenzi C, Cervia D. Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme. Sci Rep 2016;6:27281. [PMID: 27271364 DOI: 10.1038/srep27281] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
649 Gromov P, Gromova I, Friis E, Timmermans-Wielenga V, Rank F, Simon R, Sauter G, Moreira JM. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res 2010;9:3941-53. [PMID: 20527979 DOI: 10.1021/pr100160u] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
650 Sawadogo WR, Schumacher M, Teiten MH, Dicato M, Diederich M. Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochem Pharmacol 2012;84:1225-40. [PMID: 22846603 DOI: 10.1016/j.bcp.2012.07.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
651 Zhu JY, Liu CC, Wang L, Zhong M, Tang HL, Wang H. Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective study. J Cancer 2017;8:737-43. [PMID: 28382135 DOI: 10.7150/jca.17668] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
652 Bouvard B, Hoppé E, Soulié P, Georgin-Mege M, Jadaud E, Abadie-Lacourtoisie S, Petit Le Manac'h A, Laffitte A, Levasseur R, Audran M, Chappard D, Legrand E. High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy. Ann Oncol 2012;23:1151-6. [PMID: 21903604 DOI: 10.1093/annonc/mdr356] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
653 Silva JFSD, Silva AMCD, Lima-luz L, Aydos RD, Mattos IE. Correlação entre produção agrícola, variáveis clínicas-demográfcas e câncer de próstata: um estudo ecológico. Ciênc saúde coletiva 2015;20:2805-12. [DOI: 10.1590/1413-81232015209.00582015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
654 Seufferlein T, Bachet JB, Van Cutsem E, Rougier P;  ESMO Guidelines Working Group. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii33-vii40. [PMID: 22997452 DOI: 10.1093/annonc/mds224] [Cited by in Crossref: 202] [Cited by in F6Publishing: 201] [Article Influence: 22.4] [Reference Citation Analysis]
655 Kim BG, Kwon HY, Sohn EJ, Hwang S, Kwon OS, Kim SH. Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells. BMC Complement Altern Med 2014;14:420. [PMID: 25345917 DOI: 10.1186/1472-6882-14-420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
656 Steffen JA. Diffusion of molecular diagnostic lung cancer tests: a survey of german oncologists. J Pers Med 2014;4:102-14. [PMID: 25562146 DOI: 10.3390/jpm4010102] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
657 Gohil R, Rishi M, Tan BH. Pre-operative serum albumin and neutrophil-lymphocyte ratio are associated with prolonged hospital stay following colorectal cancer surgery. Br J Med Med Res 2014;4:481-7. [PMID: 24278850 DOI: 10.9734/BJMMR/2014/5444#sthash.FpqnVF8X.dpuf] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
658 Taubert H, Wach S, Jung R, Pugia M, Keck B, Bertz S, Nolte E, Stoehr R, Lehmann J, Ohlmann CH, Stöckle M, Wullich B, Hartmann A. Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients. Mol Med 2015;21:371-80. [PMID: 25998509 DOI: 10.2119/molmed.2014.00250] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
659 Tosco L, Van Poppel H, Frea B, Gregoraci G, Joniau S. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Eur Urol. 2013;63:646-652. [PMID: 23041360 DOI: 10.1016/j.eururo.2012.09.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
660 Lennox GK, Eiriksson LR, Reade CJ, Leung F, Mojtahedi G, Atenafu EG, Ferguson SE, Murphy J, Diamandis EP, Kulasingam V, Bernardini MQ. Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter? Int J Gynecol Cancer 2015;25:809-14. [PMID: 25855958 DOI: 10.1097/IGC.0000000000000442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
661 Caffo O, Veccia A, Russo L, Galligioni E. Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario. Future Oncol 2012;8:1585-95. [PMID: 23231520 DOI: 10.2217/fon.12.156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
662 Stegeman I, van Doorn S, Mallant-Hent R, van der Vlugt M, Mundt M, Fockens P, Bossuyt P, Dekker E. The accuracy of polyp assessment during colonoscopy in FIT-screening is not acceptable on a routine basis. Endosc Int Open 2014;2:E127-32. [PMID: 27054193 DOI: 10.1055/s-0034-1377173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
663 Gonçalves AR, Ferreira C, Marques A, Ribeiro LC, Velosa J. Assessment of quality in screening colonoscopy for colorectal cancer. Clin Exp Gastroenterol 2011;4:277-81. [PMID: 22235171 DOI: 10.2147/CEG.S25596] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
664 Madersbacher S, Alcaraz A, Emberton M, Hammerer P, Ponholzer A, Schröder FH, Tubaro A. The influence of family history on prostate cancer risk: implications for clinical management: FAMILY HISTORY AND PROSTATE CANCER RISK. BJU International 2011;107:716-21. [DOI: 10.1111/j.1464-410x.2010.10024.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
665 Metodieva S, Cherneva R, Nikolova D, Genchev G, Petrov D, Toncheva D. Apoptosis Gene Expression Profile in Early-Stage non Small Cell Lung Cancer. Balkan Journal of Medical Genetics 2010;13:47-52. [DOI: 10.2478/v10034-010-0026-4] [Reference Citation Analysis]
666 Izumi K, Lin WJ, Miyamoto H, Huang CK, Maolake A, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M. Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level. J Cancer Res Clin Oncol 2014;140:1413-9. [PMID: 24747988 DOI: 10.1007/s00432-014-1681-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
667 Moradi Tabriz H, Aghapour Sabaghi L, Nabighadim A, Elham E, Aghamir SMK. Evaluation of ERG Expression in Prostate Adenocarcinoma and Its Prognostic Impact in Patients Survival Rate. Iran J Pathol 2021;16:411-7. [PMID: 34567190 DOI: 10.30699/IJP.20201.530515.2644] [Reference Citation Analysis]
668 Burns R, Walsh B, O’neill S, O’neill C. An examination of variations in the uptake of prostate cancer screening within and between the countries of the EU-27. Health Policy 2012;108:268-76. [DOI: 10.1016/j.healthpol.2012.08.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
669 Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. Br J Cancer 2014;111:157-65. [PMID: 24874480 DOI: 10.1038/bjc.2014.279] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
670 Montomoli J, Hamilton-Dutoit SJ, Frøslev T, Taylor A, Erichsen R. Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study. Clin Exp Gastroenterol 2012;5:167-71. [PMID: 23028236 DOI: 10.2147/CEG.S34725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
671 Leong SP, Kim J, Ross M, Faries M, Scoggins CR, Metz WL, Cope FO, Orahood RC. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961-969. [PMID: 21331809 DOI: 10.1245/s10434-010-1524-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
672 van Blankenstein M, van Vuuren AJ, Looman CW, Ouwendijk M, Kuipers EJ. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol. 2013;48:794-800. [PMID: 23795659 DOI: 10.3109/00365521.2013.799221] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [